Barriers or bridges? by Connolly, Johnny
Improving people’s health through research and information
drugnet 
Ireland
alcohol and drug research newsletter
Issue 50 
Summer 2014
 > UN body passes  
drug resolutions
 > Annual review of the 
drug situation in Europe
 > Treated problem  
alcohol use in Ireland, 
2008–2012
 > Alcohol and youth 
mental health 
 > How attitudes to alcohol 
affect judgements about 
sexual behaviour
 > Forced labour and the 
drug trade
 > Preventing and 
responding to overdose 
 > State laboratory 
analyses street-level 
heroin and cocaine 
To have Drugnet Ireland  
delivered to your desktop,  
sign up on the NDC website
www.drugsandalcohol.ie
Prevalence of drug use 
and blood-borne viruses 
in Irish prisons
See pages 7-11.
EWODOR international 
conference held in Dublin
The European Working Group on Drugs Orientated Research (EWODOR) conference took place 
on 22–23 May in Trinity College Dublin, in partnership with Coolmine Therapeutic Community. 
This is the first time the conference has been held in Ireland. EWODOR was established in 1983 
and aims to provide a forum for researchers and health professionals in the drugs area to share 
research experience and expertise. 
Minister for State Alex White TD opened the conference, while Rowdy Yates MBE, executive 
director of EWODOR, set the scene for the participants around the theme of the conference, 
‘Gender and diversity’. There was a wide range of presentations given by 35 international 
experts and academics over the two days. The keynote speakers were: Ms Karen Biggs (Phoenix 
Futures, UK), Prof Eric Broekaert (Ghent University, Belgium), Prof Shane Butler (TCD), Dr 
Joanne Fenton (HSE), Mr Ted Fleming (NUI Maynooth), Dr Ilse Goethals (University College 
Ghent, Belgium), Ms Di Hilton (Phoenix Futures, UK), Dr Paula Mayock (TCD), Ms Mary Moore 
(Irish Probation Service), Ms Pauline McKeown (Coolmine Therapeutic Community), Ms Romy 
Paust (Coolmine Therapeutic Community), Dr Steve Pearce (NHS, UK), Ms Kathleen Yates 
(NHS, UK) and Mr Rowdy Yates MBE (University of Stirling, UK). 
A number of the delegates also gave presentations. Paula Mayock (TCD) spoke about her 
study on young women and their initiation into heroin use. Anne Marie Carew (HRB) and 
Kat Bahramian (Pavee Point) gave a joint presentation on Travellers in drug treatment. Anita 
Harris (Coolmine Therapeutic Community) presented the findings of the ‘Parenting under 
Pressure’ (PUP), the first to be run in Ireland. Di Hilton (Phoenix Futures, UK) spoke about her 
experiences of prison-based therapeutic communities in the UK.
The email and discussion list for EWODOR can be found at  
www.jiscmail.ac.uk/cgi-bin/webadmin?A0=EWODOR
(Suzi Lyons)
Prof Eric Broekaert, Ghent University, Karen Biggs, Phoenix Futures, Pauline McKeown, CEO Coolmine, 
Minster Alex White, Rowdy Yates MBE, University of Stirling, and Natalie Kennedy, Coolmine Therapeutic 
Community at the EWODOR conference. (Photo: Maxwells Photography).
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Health Research Board moves office
UN can’t agree on abolition of death 
penalty for drug offences
Ministers and government representatives attending 
the high-level segment of the 57th Session of the UN 
Commission on Narcotic Drugs (CND), held in Vienna on 
13–14 March 2014, agreed a Joint Ministerial Statement  
(E/CN.7/2014/L.15). The contents are outlined in ‘Towards 
UNGASS 2016’ elsewhere in this issue of Drugnet Ireland. 
In its report on the debate and round-table discussions 
leading to the formulation of the joint ministerial statement 
(E/CN.7/2014/16: Chapter II), the CND reported that 
Greece made a statement on the death penalty, speaking on 
behalf of the EU and its member states (including Ireland) 
and 29 other countries. The representative stated that those 
he spoke for ‘deeply regretted that the Joint Ministerial 
Statement did not include language on the death penalty, 
that they had a strong and unequivocal opposition to the 
death penalty, in all circumstances, and that they considered 
that the death penalty undermined human dignity and that 
errors in its application were irreversible’. 
The Health Research Board has moved to new offices. The new building is on the same street as our previous offices  
in Knockmaun House. The National Documentation on Drug Use is located on the ground floor of the new building.  
Our new address is:
Health Research Board  
Grattan House 
67-72 Lower Mount Street 
Dublin 2
Phone numbers, email addresses and other contact details have not been changed.
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UN body passes drug resolutions 
The Commission on Narcotic Drugs (CND), the UN’s drug 
policy-making body, met in Vienna between 13 and 21 
March 2014 for its 57th Session. For the first two days 
Ministers and representatives of member state governments 
undertook a high-level review of the Political Declaration 
and Plan of Action on International Cooperation towards 
an Integrated and Balanced Strategy to Counter the World 
Drug Problem. The conclusions of this review are described 
in ‘Towards UNGASS 2016’ elsewhere in this issue of 
Drugnet Ireland.
In the second week of the session the CND passed 11 
resolutions. They included the following:
Drug abuse prevention through sport: promoting 
a society free of drug abuse through sport and 
the Olympic ideal (E/CN.7/2014/L.4/Rev.1) 
Member states and sporting organisations are encouraged 
to use sporting events as a platform for promoting social 
inclusion and to promote equal access to sports as a means 
of drug prevention. 
Promoting prevention of drug abuse based on 
scientific evidence as an investment in the well-
being of children, adolescents, youth, families 
and communities (E/CN.7/2014/L.8/Rev.1) 
Member states are invited to expand the coverage  
and quality of drug abuse prevention systems,  
interventions, including information dissemination  
and periodic evaluations.  
 
 
Supporting recovery from substance use 
disorders (E/CN.7/2014/L.9/Rev.1) 
Member states are invited to:
 ■ improve understanding of the importance of supporting 
sustained recovery; 
 ■ provide measures to ensure non-stigmatising attitudes 
to those seeking help or in recovery, to help reduce 
marginalisation and discrimination, and to promote 
social reintegration; 
 ■ consider providing appropriate treatment and support to 
meet individual needs through the recovery process; 
 ■ gather scientific evidence on recovery and recovery-
oriented programmes; 
 ■ facilitate exchanges on developing a chronic-care 
approach to the treatment of substance use disorders 
similar to approaches for other chronic conditions ; and 
 ■ support and sustain recovery programmes in schools, 
universities, workplaces, communities and other domains.
Enhancing international cooperation in the 
identification and reporting of new psychoactive 
substances and incidents involving such 
substances (E/CN.7/2014/L.11/Rev.1)
Member states are urged to use and follow the scheduling 
processes of the 1961 Single Convention on Narcotic Drugs 
and the 1971 Convention on Psychotropic Substances , 
including providing the World Health Organization with 
timely information and identifying a national government 
focal point to coordinate information provision on substances 
for effective review by the Expert Committee on Drug 
Dependence. Member states are also encouraged to consider 
the provisional application of control measures as established 
under the 1961 and 1971 conventions to strengthen 
The Greek representative went on to state that imposing 
the death penalty for drug offences was against the norms 
of international law, specifically article 6, paragraph 2, of 
the International Covenant on Civil and Political Rights. He 
also noted the UN General Assembly resolution, supported 
by an unprecedented number of member states and 
adopted in 2012, calling for a moratorium on the use of 
the death penalty. He welcomed the recent decision by 
the International Narcotics Control Board (INCB) to call 
on countries still applying the death penalty to consider its 
abolition for drug-related offences. 
The statement by the Greek representative was supported 
by the representative for Switzerland. Speaking on behalf 
also of Norway and Liechtenstein, the Swiss representative 
said that the fight against the death penalty was an integral 
part of their human rights policies. He stated that the silence 
of the Joint Ministerial Statement on the death penalty 
was regrettable and that the Statement did not therefore 
reflect their concern about the death penalty or take into 
account the position expressed on the subject by other 
entities within the UN system, i.e. the General Assembly, 
the Human Rights Committee, the UN Secretary-General, 
the Executive Director of the UN Office on Drugs and Crime 
(UNODC) and the INCB. He requested that the report of 
the Session reflect that these countries’ agreement to the 
adoption of the Joint Ministerial Statement was given on the 
understanding that capital punishment was not compatible 
with the commitment to ensuring that the drug problem 
was addressed with full respect for all human rights and the 
inherent dignity of all individuals. 
The representative of the Islamic Republic of Iran, speaking 
also on behalf of 16 other countries, stated that the issue 
of the death penalty was not in the mandate of the CND. 
He argued that there is no international consensus on the 
abolition of the death penalty, that the death penalty is not 
prohibited under international law, including the three drug 
control conventions, and that the decision to use it or not 
is a criminal justice matter to be decided by the competent 
authorities in individual states. He concluded by stating that 
the death penalty is an important component of the system 
of the administration of law and justice and that it is imposed 
only for the most serious crimes, including drug trafficking, 
and that it serves as a deterrent. He noted that Iran has 
proper legal safeguards in place that took into account 
national policies and prevented any miscarriage of justice.
(Brigid Pike)
UN and death penalty for drug offences (continued)
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UN body passes drug resolutions (continued)
Regional drug strategies across  
the world
In March 2014 the EMCDDA released a ‘paper’ giving a 
comparative analysis of regional drug strategies across 
the world.1 The paper explores the drug strategies 
and action plans adopted over the last five years by six 
intergovernmental organisations, involving 148 countries 
in four continents. The purpose of the EMCDDA paper is 
to inform decision-makers, professionals and researchers 
working on international drug policy about the way in which 
countries in the same region have decided to strategically 
approach drug-related security, social and health problems. 
Intergovernmental organisations that  
have adopted regional drug strategies  
and actions plans
1. African Union (AU) 
2. Economic Community of West African States (ECOWAS) 
3. Organization of American States (OAS)
4. Association of Southeast Asian Nations (ASEAN)
5. Shanghai Cooperation Organisation (SCO) 
6. European Union (EU)
Drug policy principles
The EMCDDA paper analyses the main principles, objectives 
and approaches adopted in the various intergovernmental 
drug strategies. The analysis highlights five key principles 
adopted to varying degrees in the different regions: 
 ■ Respect for human rights in implementing drug policy 
is prominent in the EU, OAS and AU strategies. The EU’s 
drug strategy explicitly mentions the European Charter 
of Fundamental Rights while that of the OAS refers to the 
Universal Declaration of Human Rights. The strategies 
and plans of the ECOWAS, ASEAN and SCO organisations 
place particular emphasis on the individual’s right to 
safety and security and the threat that drug use and 
trafficking pose to these rights. 
 ■ Common and shared responsibility for drug policy, 
i.e. aiming to reconcile the goals and aspirations of 
producing and consuming countries, is strong in the  
OAS document and is mentioned in both African 
documents and in the EU strategy. 
 ■ The reduction of poverty and fostering development are 
central to both African strategies.
 ■ Effective law enforcement as the sine qua non of  
peace, security and stability is highlighted in both  
Asian strategies. 
Policy approaches 
The approach of the strategies and plans is similar, focusing 
on reducing the drugs phenomenon and organising activities 
around supply reduction and demand reduction pillars. 
The EMCDDA paper reports that there is more diversity in 
approaches to demand reduction than in those to supply 
reduction, which are relatively uniform. 
 ■ Supply reduction approaches adopt a common paradigm 
of doing ‘more and better’. More collaboration among 
national law enforcement services, more intelligence-led 
activities and more exchange of data and intelligence 
are among the measures most often mentioned. The 
intention to monitor law enforcement and supply 
reduction activities and their results is seen as ‘an 
interesting innovation’.
 ■ Preventing drug use is mentioned in all the strategies, but 
the measures described to achieve this goal are diverse, 
ranging from mass media campaigns to interventions 
tailor-made to address specific risk factors or populations.
domestic regulatory controls, particularly regarding new 
psychoactive substances, while ensuring their availability for 
medical, scientific and industrial purposes. 
Education and training on drug use disorders  
(E/CN.7/2014/L.13/Rev.1) 
Member states are invited to strengthen professional 
knowledge and skills for those working with people affected 
by substance use disorders. The resolution highlights 
the need to strengthen the capacity of competent and 
experienced trainers; to ensure that training programmes 
adopt a multi-disciplinary approach, drawing on areas such 
as medicine, psychology, education and the social sciences; 
and to strengthen intersectoral collaboration involving health 
and law enforcement professionals. 
Providing sufficient health services to individuals 
affected by substance use disorders during long-
term and sustained economic downturns  
(E/CN.7/2014/L.14/Rev.1) 
Member states are encouraged to ensure that measures 
taken at the national and local level in response to 
long-term and sustained economic downturns do 
not disproportionately affect the implementation of 
comprehensive and balanced national drug demand and 
supply reduction policies. They are also invited to continue 
providing the best attainable coverage, accessibility and 
quality with regard to health and social care services to 
all people who are or may be affected by substance use 
disorders. 
(Compiled by Brigid Pike)
 The Mentor Foundation is the only NGO working on a 
global basis to prevent drug misuse and promote health and 
well-being among children and young people.
 During the opening Queen Sylvia of Sweden, as patron 
of the Mentor Foundation, urged governments all over 
the world to reduce the availability of drugs in order to 
protect children’s lives in accordance with their recognised 
rights, and to remember that 'we cannot afford to lose our 
children'.
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Regional drug strategies (continued)
 ■ Treatment – most strategies call for evidence-based 
practice. All set the goal of drug treatment in the 
same broad terms – to treat addiction and promote 
social reintegration. Recovery from addiction and full 
reintegration and resocialisation of drug addicts into 
society is the objective most often mentioned. Some 
strategies focus on improving the effectiveness of 
treatments through better access, wider coverage and 
better quality.
 ■ Reducing harm (and risk) caused by drugs is specifically 
addressed only in the EU strategy. It is referred to in the 
OAS strategy, albeit with different wording – a reduction 
of the adverse consequences of drug abuse. 
 ■ Evaluation – the drugs strategy of the OAS is said to 
stand out because it promotes evaluation and assessment 
in all areas: ‘The document suggests integrating the 
scientific community into the design, implementation 
and evaluation of policies, and invites member countries 
to promote periodic and independent evaluations in the 
areas of demand and supply reduction, linking the results 
of evaluation to the allocation of resources.’ 
Regional policy issues
The EMCDDA paper suggests that regional drug strategies 
introduce a third political dimension, located between 
national plans, which aim to address purely national or 
local issues, and policy declarations at the UN level, which 
represent a very broad consensus. The paper highlights 
‘specificities’ that do not emerge in the UN context and 
which are too varied to be analysed at national level:
 ■ All regions express overall support for international drug 
control principles.
 ■ Drugs strategies are part of a wider regional integration 
process, often of an economic nature.
 ■ Regional drugs strategies help to foster a unified regional 
vision on drugs. 
 ■ Accountability and obligations imposed on members of 
the regional associations because of the common drugs 
strategy are largely of a political, rather than a legal or 
binding, nature.
 ■ The development of regional drugs strategies has helped 
to rebalance drugs policy, favouring a more health-
oriented approach.
 ■ Regional strategies put a strong emphasis on monitoring 
systems to collect data, analyse trends and support 
decision-making towards evidence-based policies. 
Although it is too soon to say how these regional policies will 
influence international drug control policy, the authors of the 
EMCDDA paper suggest that they represent an interesting 
policy development within the international drugs policy 
scene, and are ‘well worth a look’. 
(Brigid Pike)
1. European Monitoring Centre for Drugs and Drug Addiction 
(2014) Regional strategies across the world: a comparative 
analysis of intergovernmental policies and approaches. 
EMCDDA Papers. Luxembourg: Publications Office of the 
European Union. www.drugsandalcohol.ie/21543/ 
Towards UNGASS 2016
Ministers and government representatives attending the high-level segment of the 57th Session of the UN Commission 
on Narcotic Drugs, held in Vienna on 13–14 March 2014, agreed a Joint Ministerial Statement (E/CN.7/2014/L.15). This 
statement contains the participants’ conclusions with regard to progress in implementing the Political Declaration and Action 
Plan on the world drug problem, agreed in 2009. It will inform the preparations for and deliberations at the UN General 
Assembly Special Session (UNGASS) on the world drug problem in two years’ time. 
Excerpts from the draft statement, and summaries of certain sections, are presented below. (The numbered paragraphs below 
relate to the paragraph numbers in the draft Statement. The Statement contains 78 paragraphs in total.) 
 
Preamble
2.  The UN Conventions ‘constitute the cornerstone of the international drug control system’.
3.  ‘Commitment to achieving the targets and goals, and implementing the provisions, set out in the Political Declaration and 
Action Plan [on the world drug problem, agreed in 2009], is reaffirmed.
6.  The drug problem continues to pose a serious threat to the health, safety and well-being of all humanity, in particular 
youth – 15 years after the commitments made at the last UNGASS on the world drug problem to a drug-free world.
8.  Member states reaffirm their ‘determination to tackle the world drug problem and to actively promote a society free of 
drug abuse in order to ensure that all people can live in health, dignity and peace, with security and prosperity.’
11.  In light of discussions in some regions on how to address the world drug problem, member states emphasise the 
importance of ‘a broad, transparent, inclusive and scientific evidence-based discussion’.
15.  The role of civil society in addressing the world drug problem merits special mention. Member states note its ‘important 
contribution to the review process’ and that representatives of affected populations and civil society entities ‘should be 
enabled to play a participatory role in the formulation and implementation of drug demand and supply reduction policy’.
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Towards UNGASS 2016 (continued)
General achievements, challenges and priorities for action
17 & 19.  The global illicit supply of and demand for narcotic drugs and psychotropic substances under international control 
has remained ‘largely stable during the past five years’. There is now a better understanding of the problem, 
more widespread development and use of national strategies, updating of legal frameworks, and the creation and 
strengthening of capacities within law enforcement and health institutions.
23.    The world drug problem ‘should continue to be addressed in a comprehensive, integrated and balanced manner, 
in full conformity with the three drug control conventions ... as well as all human rights, fundamental freedoms and 
the inherent dignity of all individuals’. 
25–29.   Member states specifically note the need for strengthening the partnerships between public health, justice and law 
enforcement sectors, a better understanding of the social and economic drivers of the world drug problem, the 
emerging challenge of polydrug ‘abuse’ in some regions, the serious and evolving challenge that amphetamine-
type stimulants continue to pose for international drug control efforts, and the danger that economic and financial 
constraints may disproportionately impact on drug policies, in particular ‘adequate provisions of related  
health measures’.
A. Demand reduction – achievements, challenges and priorities for action
1 & 3.   Member states recognise that ‘drug addiction is a health problem’. They also note that various member states have 
implemented comprehensive drug demand reduction programmes and ‘a broad range of alternatives to conviction 
and punishment in appropriate drug-related cases of a minor nature or in cases in which the person who abuses 
drugs has committed an offence as outlined in the relevant provisions of the international drug control conventions’.
6–13.   Member states need to increase focus, in conformity with the three international drug control conventions, on:
 ■  drug-related health effects, taking into account the specific challenges faced by vulnerable groups such 
as children, adolescents, vulnerable youth, women, including pregnant women, people with medical and 
psychiatric comorbidities, ethnic minorities and socially marginalised individuals; 
 ■ formulating and implementing a broad system of primary prevention and early intervention;
 ■ strengthening public health systems, particularly in the areas of prevention, treatment and rehabilitation;
 ■ developing or strengthening national monitoring mechanisms that collect and analyse data on current trends in 
demand, including possible gaps in the provision of appropriate public health, educational and social services;
 ■ ensuring access for all to comprehensive drug demand reduction measures, taking into account the specific 
needs of women and children;
 ■ reducing the transmission of HIV among injecting drug users by 50% by 2015;
 ■ implementing measures aimed at minimising the negative public health and social impacts of drug ‘abuse’;
 ■ deepening knowledge of the challenges posed by new psychoactive substances (NPS) and developing 
comprehensive and integrated approaches to the detection, analysis and identification of NPS, trends and 
possible negative health and other impacts.
B. Supply reduction – achievements, challenges and priorities for action
15.   Progress was noted with respect to measures related to the illicit production and supply of narcotic drugs and 
psychotropic substances, including the exchange of information and best practices, regional and international 
coordination, capacity building, cross-border operations and maritime control. Progress was also noted in the 
development of a consolidated international response to the increasing availability of NPS that may pose risks to 
public health and safety, including the development of a global reference point, the Early Warning Advisory and 
cooperation in the identification and reporting of such substances, in order to increase data collection, improve 
collective understanding and find effective policy responses.
22.   Law enforcement measures alone cannot address the challenges. 
23.   There is a need to ‘scientifically evaluate, where appropriate, drug supply reduction measures, in order to direct 
government resources to initiatives that have proved to be successful.’
24–25.  There is an urgent need to respond to the serious challenges posed by the increasing links between drug trafficking 
and corruption, organised crime, terrorism and money-laundering. ‘The effective application of and respect for 
the rule of law contributes to combating the world drug problem and facilitates efforts to hold drug traffickers and 
perpetrators of related crimes accountable for their actions.’
28–32.  Specific supply reduction challenges include new psychoactive substances; synthetic opioid analgesics not under 
international control, in particular tramadol; precursor chemicals; and the illicit cultivation of opium poppy, coca bush 
and cannabis plant and illicit drug production, manufacture, distribution and trafficking. 
(Compiled by Brigid Pike)
17. & 
20.
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Prevalence of drug use and blood-borne 
viruses in Irish prisons, 2011
Background
The National Advisory 
Committee on Drugs 
and Alcohol (NACDA) 
has published the 
results of a survey 
estimating the extent 
of drug use and the 
prevalence of blood-
borne viruses among 
the prison population 
in Ireland.1 The survey 
questionnaire was 
completed by a random 
sample of prisoners 
between February and 
April 2011. Oral fluid 
samples were obtained 
to assess use of specific 
drugs (cannabinoids, opiates, methadone, cocaine and 
benzodiazepines) in the 24 to 72 hours preceding the survey 
and to detect the presence of hepatitis B, hepatitis C and 
HIV infections. Flexibility was required in different prisons to 
accommodate prison schedules, security arrangements and 
prisoner availability. 
Of the 1,666 randomly selected prisoners, 824 took part in 
the study, giving a response rate of 49.5%, which is much 
lower than that achieved in previous Irish prison studies2-4 
and lower than that required for a robust prevalence 
estimate. Completed questionnaires and oral fluid analysis 
were available for 46% (771/1,666) of invited participants. 
Of the 886 prisoners who attended the information session, 
7% (62) declined to participate in the study. Field workers 
reported that reasons given by 47% (780) of prisoners for 
not attending the information session included unavailability, 
attendance at the gym, school or workshop, mistrust, 
suspicion, cynicism, apathy, and concerns regarding 
mandatory drug testing and DNA sample collecting. 
Most respondents were male (95%) and Irish (92%). The 
average age was 31 years, and 50% were aged 28 years or 
under. Almost one-in-four respondents (23%, 186) received 
no schooling or primary education only compared to one-in-
five of the general population in Ireland and only 13% (105) 
reported having some third-level or completed third-level 
education compared to 31% in the general population. Sixty 
per cent (483) had been in custody for more than one year, 
and 52% (419) had spent more than three of the past ten 
years in prison. More than one in ten had been homeless for 
more than seven days in the year before the survey. More 
women (46%) than men (22%) reported that they had been 
homeless in the 12 months prior to the survey. 
This article summarises four key areas addressed in  
the report:
 ■ prevalence of drug use among prisoners;
 ■ prevalence of injecting drug use;
 ■ prevalence of blood-borne viral infection; and
 ■ prison drug treatment and harm-reduction services.
Prevalence of drug use
Lifetime prevalence (ever used)
The drugs most commonly used among the prison 
population were cannabis (87%), cocaine powder (74%) and 
benzodiazepines (68%) (Table 1). There was no difference 
between men’s and women’s lifetime use of cannabis, 
cocaine or benzodiazepines (Tables 2−5). Lifetime heroin use 
was high at 43% (Table 4). Women were significantly more 
likely than men to use heroin (64%), methadone (60%) and 
crack cocaine (59%) at some point in their life (Tables 2−5). 
It is important to note that some of the methadone and 
benzodiazepine use was prescribed, and most of the illicit 
drug use occurred outside the prison environment.
Last-year prevalence (recent use)
Cannabis, at 69%, was the drug most commonly used in 
the year prior to the survey, followed by benzodiazepines, 
at 55% (Table 1). The 25–34-year-olds were significantly 
more likely to have used heroin (36%) compared to the older 
(20%) or younger (30%) age groups (Table 4). Of those 
who had used a drug in the last year, a majority in each case 
had used the drug while in prison: 88% had used cannabis; 
85% benzodiazepines; 87% other sedatives or tranquillisers; 
87% methadone; 84% heroin; 66% other opiates; and 52% 
crack cocaine.
Table 1  Prevalence of drug use among Irish prisoners, inside or outside prison, 2011 
Cannabis
Cocaine 
powder Crack cocaine Heroin Methadone Benzodiazepines
Other 
sedatives or 
tranquilisers
Lifetime use  
(ever used)
708 (86.9%) 600 (74.2%) 284 (35.6%) 348 (43.3%) 262 (32.6%) 547 (67.8%) 466 (58.2%)
Last-year  
(recent) use
554 (68.6%) 226 (28.6%) 92 (11.7%) 233 (29.5%) 167 (20.9%) 434 (54.6%) 367 (46.3%)
Last-month 
(current) use
349 (43.4%) 41 (5.3%) 15 (1.9%) 87 (11.1%) 106 (13.3%) 229 (29.0%) 367 (46.3%)
Past 24–72  
hour use
31 (4.0%) Not available Not available 2* (0.3%) 103 (13.3%) 83 (10.7%) Not available
*Opiates
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Last-month prevalence (current use) 
Cannabis (43%) was the drug most commonly used in the 
past month, followed by benzodiazepines (29%). One-
hundred-and-three prisoners (13%) tested positive for 
methadone in the 24 to 72 hours prior to the survey and 
106 reported being prescribed methadone daily in the last 
month. Eighteen per cent of those who tested positive for 
methadone were in the 25–34-year age group. Women were 
significantly more likely to test positive for methadone than 
men (33% vs 12%). 
Use in previous 24–72 hours
Oral fluid sample testing for drug use in the previous 24–72 
hours found that proportionally more women than men 
were on daily methadone maintenance. Four per cent (31), 
all men, had used cannabis in the 24–72 hours before the 
survey, and 11% (83) had used benzodiazepines. Women 
(20%) were two times more likely to test positive for 
benzodiazepine use than men (10%). 
Methods of heroin use 
Two-hundred-and-twenty-six prisoners said they were ’doing 
heroin now’. Seventy-five per cent of current heroin users 
reported smoking (or chasing the dragon) as their only 
method of choice, with 13% reporting injecting and 1% 
snorting as their only method. Only a very small proportion 
(1.3%) currently used all three methods of administration. 
The proportion of those who smoked and snorted was 1.3%, 
whereas 9% both smoked and injected. 
Prescription drug use in prison 
High usage of benzodiazepines and other sedatives and 
tranquillisers, and of methadone and other opiates was 
reported by participants. The vast majority (85%) of 
prisoners who reported taking methadone in prison in  
the month prior to the survey had taken it on prescription.  
A minority of prisoners had taken benzodiazepines (14%) 
and other sedatives (22%) under medical supervision (or  
on prescription). A large proportion reported having  
taken unprescribed benzodiazepines in prison in the  
previous month. 
Lifetime prevalence (ever injected)
Over 26% reported having ever injected drugs, with women 
(44%) more likely to have a lifetime history of injecting drug 
use than men (24%). Thirty-four per cent of the 25–34-year 
age group were more likely to have injected than their older 
(22%) or younger counterparts (18%). The most common 
drug injected was heroin (19%), followed by cocaine powder 
(13%). Women were more likely than men to have injected 
heroin (43% vs 18%), cocaine powder (32% vs 12%), 
mephedrone (16% vs 4%), methylone (11% vs 2%) and any 
other drug (14% vs 4%). 
Last-year prevalence (recent injectors)
The most commonly injected drug in the last year was heroin 
(7%), followed by cocaine powder (3%), benzodiazepine 
(3%) and steroids (2%). More women than men had 
injected heroin (21% vs 6%), cocaine powder (14% vs 
3%), mephedrone (13% vs 2%), methylone (7% vs 1%), 
amphetamines (7% vs 1%) and benzodiazepines (11% vs 
2%), with no significant differences across age groups.
Last-month prevalence (current injectors)
The numbers reporting injecting in the last month were low 
(1 to 8 people injecting each drug). Cocaine powder was 
injected by eight respondents (1%), heroin by seven (0.9%), 
benzodiazepines by four (0.5%) and steroids by four (0.5%). 
Age at first use of drugs
Fifty per cent of cannabis users had used it by their 14th 
birthday. Half of all benzodiazepines users had used it by 
their 17th birthday. The median age for first use of cocaine 
powder was 18 years, and for heroin 19 years. Among heroin 
injectors, the average length of time between moving from 
smoking to injecting heroin was 2.8 years. The median 
age for commencing injecting head shop drugs such as 
methylone and mephedrone was 24 years, and for steroid 
injecting 22 years. 
First use and first injection 
Of those who reported having ever used heroin (smoking 
or injecting), 146 (43%) said they had taken it for the first 
Table 2  Prevalence of cannabis use among Irish prisoners, inside or outside prison, by age and gender, 2011
Cannabis use All Male Female 18–24 years 25–34 years 35–64 years
Lifetime use  
(ever used)
708 (86.9%) 670 (87.0%) 38 (84.4%) 241 (94.9%) 297 (92.5%) 162 (70.4%)
Last-year  
(recent) use
554 (68.6%) 523 (68.6%) 31 (68.9%) 210 (84.0%) 231 (72.6%) 105 (45.7%)
Last-month 
(current) use
349 (43.4%) 332 (43.7%) 17 (38.6%) 128 (51.2%) 148 (46.8%) 67 (29.4%)
Past 24–72  
hour use 
31 (4.0%) 31 (4.2%) 0 9 (3.8%) 14 (4.5%) 8 (3.8%)
Table 3  Prevalence of cocaine use among Irish prisoners, inside or outside prison, by age and gender, 2011
Cocaine use All Male Female 18–24 years 25–34 years 35–64 years
Lifetime use  
(ever used)
600 (74.2%) 571 (74.6%) 29 (65.9%) 210 (83.7%) 262 (81.9%) 121 (53.1%)
Last-year  
(recent) use
226 (28.6%) 208 (27.8%) 18 (41.9%) 96 (38.9%) 101 (32.3%) 26 (11.8%)
Last-month 
(current) use
41 (5.3%) 40 (5.4%) 1 (2.4%) 11 (4.6%) 19 (6.1%) 10 (4.6%)
Past 24–72  
hour use 
1 1 Not available Not available 1 Not available
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time in prison and these were more likely to be men (46%) 
than women (17%). Twenty-one per cent of women and 6% 
of men (8% overall) who had ever injected heroin reported 
having injected it for the first time in prison. Of the 69 who 
had started injecting in prison, 16 (24%) injected steroids 
while 12 injected heroin.
Of injectors who had injected in the past year, 13 of the  
19 recent steroid injectors had injected in prison, 9 of  
56 recent heroin injectors had done likewise, as had 7 of  
23 recent benzodiazepine injectors and 7 of 25 recent 
cocaine injectors. 
Prevalence of blood-borne viral infection 
Risk factors for viral infection reported by prisoners were:
 ■ Sharing injecting paraphernalia: Of those who reported 
having ever injected drugs and answered the questions 
on sharing equipment, 48.8% (84/172) shared needles, 
49% (81/165) syringes and 52% (84/162) other injecting 
equipment. A greater proportion of females (78%) 
reported sharing needles and syringes compared to 
males (46%). 
 ■ Sexual behaviour: Self-reported rates of unprotected sex 
(having sex without a condom) were high both while in 
prison (62%) and outside prison (51%). Less than 2% of 
men reported that they had ever had sex with other men 
(1.5% outside prison and 0.9% in prison). 
 ■ Tattooing: More than two-thirds (68%) of participants 
had borstal or tattoo markings, and 35% had had a 
tattoo done in prison. 
Hepatitis C prevalence: oral fluid test
The overall prevalence of hepatitis C was 12.9% among the 
prisoners tested, and 41.5% (83/200) among those who 
were injecting drug users (Figure 1). Prevalence of hepatitis 
C varied with the type of drug injected; the proportion of 
positive hepatitis C tests among different injector types were: 
54% (80/149) of heroin injectors tested positive for hepatitis 
C, 66% (66/100) of cocaine injectors, and 62% (42/68) 
of benzodiazepine injectors, and 27% (14/66) of steroid 
injectors (Figure 2). It is important to note that National 
Drug Treatment Reporting System data indicates that there 
is likely to be significant overlap between heroin, cocaine 
and benzodiazepine injectors. The prevalence rate in the Irish 
population has been estimated at 0.5–1.2%5 – much lower 
than the rate experienced by either prisoners or injecting 
drug users. 
A previous study reported a prevalence rate for hepatitis C of 
37% among prisoners and 81% among injectors; however, 
these were mainly heroin injectors.2
The concordance analysis revealed that 21 (9%) of those 
who thought they were negative had a positive test result 
and three (1%) of those who reported being positive had a 
negative test result. 
Multivariate analysis indicated that five factors were 
associated with hepatitis C infection: being female, being 
over 25 years old, having a history of injecting drug use, 
sharing injecting equipment and having had tattoos done  
in prison. 
Hepatitis B prevalence: oral fluid test
The prevalence of hepatitis B was 0.3% among the prisoners 
tested. The prevalence of hepatitis B in the general 
population in Ireland is low (< 1%).6 
A previous prison study found prevalence rates for hepatitis 
B of 9% among prisoners and 18.5% among injectors in 
prison.2 The introduction of blood-borne viral testing and 
hepatitis B vaccination in the Irish Prison Service in 1995 
accounts for the reduction of hepatitis B infection among 
drug users in prison.
The concordance analysis indicated that eight people (3%) 
think they have a disease that they do not have and one 
person (0.4%) has a disease that he does not know he has 
and may not be taking the necessary precautions to prevent 
spread of infection to others. 
Table 5  Prevalence of benzodiazepine use among Irish prisoners, inside or outside prison, by age and gender, 2011
Benzodiazepine 
use
All Male Female 18–24 years 25–34 years 35–64 years
Lifetime use  
(ever used)
547 (67.8%) 516 (67.7%) 31 (68.9%) 203 (80.2%) 229 (71.8%) 109 (48.4%)
Last-year  
(recent) use
434 (54.6%) 406 (54.1%) 28 (62.2%) 174 (69.3%) 188 (59.9%) 68 (30.9%)
Last-month 
(current) use
229 (29.0%) 211 (28.3%) 18 (40.0%) 79 (31.5%) 106 (34.0%) 43 (19.7%)
Past 24–72  
hour use 
83 (10.7%) 74 (10.1%) 9 (20.0%) 25 (10.4%) 40 (12.9%) 18 (8.5%)
Table 4  Prevalence of heroin use among Irish prisoners, inside or outside prison, by age and gender, 2011
Heroin use All Male Female 18–24 years 25–34 years 35–64 years
Lifetime use  
(ever used)
348 (43.3%) 319 (42.1%) 29 (64.4%) 94 (37.8%) 159 (50.2%) 90 (39.7%)
Last-year  
(recent) use
233 (29.5%) 212 (28.4%) 21 (46.7%) 74 (29.7%) 112 (36.0%) 45 (20.4%)
Last-month 
(current) use
87 (11.1%) 81 (11.0%) 6 (13.3%) 27 (10.9%) 40 (12.9%) 19 (8.8%)
Past 24–72  
hour use 
2* (0.3%) 2* (0.3%) 0 0 1* (0.3%) 0
*Opiates
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HIV prevalence: oral fluid test
Fifteen participants tested positive for HIV, resulting in a 
prevalence of 1.9% among prisoners and 6.0% among 
injecting drug users in prison (Figure 1). Figure 2 presents 
the prevalence of HIV among injecting drug users by type  
of drug injected and demonstrates that the prevalence of  
HIV is between 7% and 10% among hard drug users.  
The Irish population prevalence is estimated to be 0.2% 
(15–49-year- olds).7
In a previous Irish prison study, prevalence of HIV was 2% 
among all prisoners and 3.5% among injectors.2
The concordance analysis revealed three (1.4%) people who 
thought they were negative were positive and one (0.4%) 
prisoner who thought he was positive was negative. 
While the numbers who tested positive for HIV were small 
(15/657), four factors were found to be associated with  
HIV infection: being female, having a history of injecting 
drug use, sharing injecting equipment, and male-to-male 
sexual contact. 
Steroid injectors
Of note, there were 69 self-reported steroid injectors, of 
whom 16 had started to inject in prison and 13 had injected 
in prison in the last year. Fourteen steroid injectors tested 
positive for hepatitis C and two for HIV. This study identifies a 
new cohort of injecting drug users and hepatitis C infection.
Co infection: oral fluid test
Fourteen per cent (106/777) of prisoners had serological 
evidence for blood-borne virus infection. No prisoner tested 
positive for all three viruses, and there was no co-infection 
with hepatitis B and HIV. However, 10 participants (1.3%) 
were found to be co-infected with hepatitis C and HIV. One 
(0.1%) was co-infected with hepatitis B and hepatitis C. The 
one factor identified as being significantly associated with co-
infection was ever having shared injecting drug equipment. 
Prison drug treatment and harm-reduction 
services
Participants were asked if they ever needed different types of 
drug treatment or harm reduction services while in prison. 
They were also asked whether those services were available 
to them (within a reasonable time frame) and, if available, 
whether they used those services. The different types of 
service were analysed by overall prison population, then by 
prison drug use category (see box) and by injecting drug 
use. Some of the main results are summarised below.
Overall treatment needs
The greatest proportion of respondents expressed a need 
for addiction counselling in prison (44%), while the smallest 
proportion expressed a need for alcohol detoxification 
(14%). Nineteen per cent of participants expressed a need 
for benzodiazepine detoxification, and the same proportion 
expressed a need for opiate detoxification.
The availability of specific drug treatments varied among 
participants who expressed a need for them. It ranged from 
low (22% for benzodiazepine detoxification) to high (73% 
for methadone maintenance treatment). 
Overall, a high proportion of participants who needed a 
drug treatment service, and for whom it was available in 
prison, used the service, ranging from 95% for methadone 
maintenance to 78% for alcohol detoxification. The authors 
note that availability also varied across prisons (see below). 
Need by prison drug use category
The need for services varied by prison drug use category. As 
might be expected, the expressed need was highest in the 
‘very high’ drug use category prisons. The highest need in all 
prison categories was for addiction counselling, ranging from 
56% in the ‘very high’ drug use category to 38% in the ‘low’ 
drug use category. The need for a more specific intervention, 
methadone maintenance treatment (MMT), ranged from 6% 
in the ‘low’ drug use category to 46% in the ‘very high’ drug 
use category.
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An analysis of the reported availability of services (among 
those who needed them) by prison drug use category was 
also done. This showed a wide range of availability across 
categories. For example, in ‘very high’ drug use prisons 
88% reported that MMT was available, compared to 49% 
in ‘medium’ drug use prisons. In the ‘very high’ drug use 
prisons, availability of drug-free wings or landings (28%)  
or drug-free programmes (32%) was reported as low.  
Where these services were available there was high  
uptake, particularly in the ‘high’ and ‘very high’ drug  
use category prisons. 
A sub-group of participants comprising those who had  
ever injected (IDUs) was analysed by prison drug use 
category. The expressed need for services was higher across 
all categories of prison drug use. The need was particularly 
high for addiction counselling (ranging from 62% to 82%) 
and drug-free treatment programme (ranging from 53%  
to 74%). The authors state that the results for the availability 
of services and high uptake of services for this group  
were similar to those in the general prison population as 
reported above. 
Overdose history 
While over a quarter (27%) of all prisoners reported ever 
overdosing, the proportion among injecting drug users 
was much higher (58%). There were significant differences 
between genders, as women were more likely than men 
to report a history of overdose (44% compared to 26%). 
This difference was even more apparent for injecting drug 
users (80% compared to 55%). There were no significant 
differences between the age groups. 
Almost a quarter (24%) of participants reported the need 
for information on overdose prevention, but only a quarter 
(25%) of those reported that it was available. However, 
where the information was available, almost all (88%) were 
able to access it.
As might be expected, the expressed need for this 
information was highest in the ‘very high’ drug use prison 
category (33%) and lowest in the ‘low’ use category (17%). 
In spite of the high number who reported ever overdosing, 
participants reported limited availability of this information 
for those who needed it in the ‘high’ (27%) and ‘very high’ 
(25%) category prisons. However, where this information 
was available, there was very good uptake, ranging from 
75% in the ‘low’ use category to 100% in the ‘very high’  
use category prisons.
Key messages
The authors conclude that prisoner populations reflect a 
profile of social disadvantage and the verified reported 
rates for drug use8 and blood-borne viral infections are 
much higher than those in the general population.5-7 A 
considerable proportion of all prisoners reported ever 
overdosing, the proportion among injecting drug users was 
much higher. Where drug treatment is available, its uptake is 
very high.
Recommendations for drug treatment
 ■ Prisoners on methadone treatment should be placed 
on an HSE clinic list or GP list to ensure that there is 
continuity of treatment on release from prison. This 
would reduce the risk of overdose and early relapse.9
 ■ If a prisoner is engaging with counselling, where possible 
there should be continuity of this treatment on release  
in order to support transition out of prison and into  
the community.9
 ■ A full range of drug treatment, encompassing an 
integrated clinical and psychological approach, should be 
available in all closed prisons.9
 ■ There is a need for drug-free wings and drug-free areas 
not only for prisoners who do not use drugs but for those 
who wish to prevent relapse.9
 ■ As the women’s prison was included in the ’very high 
drug use‘ category of prison, it is recommended that 
there be a specific strategy for the needs of women in 
order to improve their outcomes.9 
Recommendation for overdose
 ■ There is a need for a health promotion strategy in the 
prisons to include overdose prevention.
(Carrie Garavan, Jean Long and Suzi Lyons)
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Prison drug use category
The authors used a post-hoc hierarchical clustering 
model to categorise prisons based on prisoners’ self-
reported use in the previous 12 months of the six drugs 
included in the EMCDDA ‘problem drug use’ definition.
By this method they identified four prison clusters based 
on levels of drug use, which they categorised as ‘low’, 
‘medium’, ‘high’ and ‘very high’.
(For detailed description of the method used, see pp. 
38–41 of the report.)
12
drugnet 
Ireland
Annual review of the drug situation  
in Europe
The European 
Monitoring Centre 
for Drugs and 
Drug Addiction 
(EMCDDA) published 
European drug 
report 2014: trends 
and developments 
on 27 May.1 The 
report summarises 
the latest trends 
across the 28 EU 
member states, and 
Norway and Turkey. 
Accompanying the 
report is a series of 
online interactive 
Perspectives on 
Drugs (PODs) 
providing deeper 
insights into important issues. The Health Research Board 
(HRB) provides the Irish figures for the EMCDDA report. 
The EMCDDA reports an overall stable situation and 
decreases in the use of the more established drugs. In 
the case of synthetic drugs, including stimulants, new 
psychoactive substances and medicinal products, the 
situation is becoming increasingly complex as these drugs 
become more prominent in drug markets in Europe. Both 
the quantity of heroin and the number of seizures have 
fallen considerably in recent years and the numbers entering 
treatment for heroin use continue to decline. There are an 
estimated 1.3 million problem opioid users in Europe and 
increasing numbers of those entering treatment for the first 
time are using synthetic opioids. Opioids were implicated in 
most of the 6,100 overdose deaths in Europe in 2012.  
There are wide national variations in both the number of 
overdose deaths and the proportion of deaths attributable  
to synthetic opioids. 
Commenting on the report, European Commissioner for 
Home Affairs Cecilia Malmström said: ‘This annual analysis 
from the EMCDDA provides us with a critically important 
window on Europe’s evolving drugs problem. I am deeply 
concerned that the drugs consumed in Europe today may be 
even more damaging to users’ health than in the past. There 
are signs that the ecstasy and cannabis sold on the street 
are getting stronger. I also note that the EU Early Warning 
System, our first line of defence against emerging drugs, is 
coming under growing pressure as the number and diversity 
of substances continue to rise sharply.’ 
EMCDDA Director Wolfgang Götz added: ‘We see that 
progress has been made in Europe on some of the major 
health policy objectives of the past. But the European 
perspective can obscure some important national differences. 
Our latest data show how encouraging overall EU trends 
on overdose deaths and drug-related HIV infections, for 
example, sit in sharp contrast to worrying developments in a 
few Member States.’ 
Cannabis
 ■ The EMCDDA estimates that around 14.6 million  
young Europeans (aged 15–34), used cannabis in the  
last year, 8.5 million of these aged 15–24 (13.9% of  
this age group).
 ■ The use of cannabis in Europe has stabilised or is 
declining, especially among younger age groups.  
The situation does vary between countries. Of the  
13 countries that have conducted new surveys since 
2011, five reported an increase in last-year prevalence 
among young people (aged 15–34) and eight reported 
a decrease.
 ■  Around 1% of European adults (aged 18–64) use 
cannabis on a daily, or almost daily, basis. In 2012 clients 
entering drug treatment for the first time identified 
cannabis as their main problem drug more frequently 
than any other drug.
 ■  In Europe more than three-quarters of reported drug 
offences involve cannabis. While the focus has been 
on controlling the supply and trafficking of cannabis 
rather than on personal use, the numbers of reported 
possession and use offences have increased steadily over 
the past decade.
 ■  Public opinion surveys in Europe show that attitudes are 
polarised around the legal status of cannabis. Regulatory 
changes in some states in the US and in some Latin 
American countries have contributed to this debate.
Opioids (mainly heroin)
 ■  The average prevalence of problem opioid use among 
adults (aged 15–64) in 2012 is estimated at around 
0.4%. This is the equivalent of 1.3 million problem 
opioid users in Europe.
 ■  In Europe 46% (180,000) of all clients who entered 
treatment in 2012 were users of opioids (mainly heroin).
 ■  The number entering specialist drug treatment for the 
first time for heroin use fell from a peak of 59,000 in 
2007 to 31,000 in 2012, accounting for 26% of all 
clients entering treatment for the first time.
 ■  In 17 European countries more than 10% of first-time 
opioid clients entering specialised treatment in 2012 
were misusing opioids other than heroin, including 
methadone, buprenorphine and fentanyl. In some 
countries, these drugs now represent the most common 
form of opioid use.
 ■  The number of opioid users for whom injecting is the 
main route of administration has fallen since 2006. Of 
the opioid clients entering treatment in 2012, 38% 
reported injecting the drug.
 ■  Injecting continues to play a major role in the 
transmission of blood-borne infectious diseases such 
as hepatitis C and, in some countries, HIV/AIDS. There 
were 1,788 newly reported HIV diagnoses attributed to 
injecting drug use in 2012, slightly more than in 2011 
(1,732), continuing the upward trend observed since 
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2010. Across the 18 countries for which data are available 
for the period 2011–12, injecting drug use accounts for 
an average of 64% of all hepatitis C virus (HCV) diagnoses 
and 50% of the acute diagnoses notified (where the risk 
category is known).
 ■  Drug use is one of the major causes of mortality among 
young people in Europe. Heroin or other opioids are 
present in the majority of reported fatal overdoses. Most 
countries reported an upward trend in the number of 
overdose deaths from 2003 up to 2008/09, when overall 
levels first stabilised and then began to decline. Overall, 
around 6,100 overdose deaths were reported in 2012. 
This is similar to the number reported in 2011, which 
represented a decrease from the 6,400 cases in 2010 and 
7,100 in 2009. Typically, those dying of drug overdoses 
are in their mid-thirties or older, and their average age at 
death is rising, suggesting an ageing cohort of problem 
opioid users. 
 ■  The quantity of heroin seized in 2012 (5 tonnes) was the 
lowest reported in the last decade, and equivalent to only 
half of the quantity seized in 2002 (10 tonnes). Declining 
seizures in the EU have been accompanied by increasing 
seizures in Turkey where, each year since 2006, more 
heroin has been seized than in all EU countries combined.
Cocaine
 ■ Cocaine is the most commonly used illicit stimulant 
drug in Europe, although most users are found in a small 
number of countries. It is estimated that about 2.2 million 
young adults aged 15–34 (1.7% of this age group) used 
cocaine in the last year.
 ■  Denmark, Spain and the United Kingdom, countries 
which have had highest prevalence rates for cocaine use 
among young adults over the past few years, reported 
a peak in use in 2008 and a steady decline since then. 
Recent data from 11 of the 12 countries reporting 
on surveys between 2011 and 2013 show a fall in 
prevalence.
 ■  Cocaine was the main problem drug for 55,000 (14%) 
clients entering specialised drug treatment in 2012. 
The number of clients entering treatment for the first 
time who cited cocaine as their primary drug has been 
decreasing in recent years, from a peak of 38,000 in  
2008 to 26,000 (18% of all first-time entrants to 
treatment) in 2012.
 ■  Across the 19 countries reporting data, at least 500 
deaths related to cocaine use were recorded in 2012.  
This is a slight increase from 2011 when there were  
475 deaths recorded.
 ■  In 2012, around 75,000 seizures of cocaine were reported 
in the European Union. There has been a continuous 
decline in the number of such seizures since 2008, when 
95,000 were reported. The quantity of cocaine seized has 
also declined, from a peak of 120 tonnes in 2006 to 71 
tonnes in 2012.
Other stimulants and new psychoactive 
substances
 ■  Data on new psychoactive substances (NPS) are based on 
notifications by member states to the EU Early Warning 
System (EWS). During 2013 the EWS identified 81 NPS, 
29 of which were synthetic cannabinoids, 13 were  
new substituted phenethylamines, seven were synthetic 
cathinones, one was a tryptamine and one a piperazine, 
and 30 were compounds which did not conform to the 
readily recognised chemical groups (including plants  
and medicines).
 ■  Since 2005 the EWS has identified more than 50 
substituted cathinones, the best known example of which 
is mephedrone, controlled in Europe since 2010 and 
becoming increasingly important in the stimulants market 
in some countries. Cathinones are generally snorted but 
there is evidence of increased rates of injecting among 
high-risk users in some countries.
 ■  Around 1.5 million Europeans used amphetamines during 
the last year. There appears to be some geographical 
spread in the use of methamphetamines beyond the 
Czech Republic and Slovakia, but use remains low.
 ■  Ecstasy refers to the synthetic substance MDMA. The 
quantity of ecstasy tablets seized in Europe has been 
increasing slowly since 2009 after a steady decline 
over the previous seven years. Ecstasy producers have 
reportedly responded to strengthened controls and the 
targeted seizure of PMK, the main precursor chemical 
for the manufacture of MDMA, by using non-controlled 
substances and converting them into the precursor 
chemicals necessary for MDMA production.
EMCDDA Perspectives on Drugs
Along with its European drug report 2014 the EMCDDA 
provides additions to its Perspectives on drugs (PODs) series, 
published online.2 These PODs provide reviews of key aspects 
of the European drug situation. The new PODs explore: 
 ■  Emerging concerns relating to stimulant use, with a focus 
on cathinones detected in the last few years and trends in 
injecting of these drugs;
 ■  New developments in Europe’s cannabis market, with 
particular interest in the increasing dominance of 
domestically-cultivated herbal products and the rise in 
potency of both herbal and resin forms of the drugs;
 ■  Internet-based treatment, noting the developments in 
this area over the past 10 years and the integration of 
tested psychosocial techniques into new web-based 
delivery systems;
 ■  Medications to treat cocaine dependence, which reports 
on a study of a number of reviews. The study concludes 
that psychosocial interventions remain the mainstay of 
treatment for problem cocaine use. 
(Brian Galvin)
1. European Monitoring Centre for Drugs and Drug Addiction 
(2014) European drug report 2014: trends and developments. 
Luxembourg: Publications Office of the European Union. 
www.drugsandalcohol.ie/21957 
2. The PODs and national data and statistics are also available at 
www.emcdda.europa.eu/edr2014
Annual review of drugs in Europe (continued)
Statistical data reported here are for 2012 or the most 
recent year available. European totals and trends are 
based on those countries providing sufficient and 
relevant data for the period specified.
14
drugnet 
Ireland
Treated problem alcohol use in Ireland, 
2008–2012
The National Drug Treatment 
Reporting System (NDTRS) 
has published the latest figures 
on treated problem alcohol 
use in Ireland in the years 
2008–2012.1 Some of the main 
results are summarised below.
The annual number of cases 
treated for problem alcohol 
use increased from 7,940 in 
2008 to a peak of 8,604 in 
2011, decreasing in 2012  
to 8,336.
The number of new cases 
treated rose by 17.9%, from 3,833 in 2008 to 4,520 in 2011, 
but dropped to 4,028 in 2012. The number of previously 
treated cases who returned to treatment increased by 16.8% 
over the period, from 3,606 cases in 2008 to 4,212 in 2012. 
Both the incidence and prevalence of treated problem 
alcohol use per 100,000 15–64-year-olds living in Ireland 
increased in each of the years between 2008 and 2011; both 
rates subsequently decreased in 2012 (Figure 1): 
 ■  The incidence increased from 119.7 in 2008 to 141.2 in 
2011 and subsequently decreased to 125.1 in 2012.
 ■  The prevalence increased from 248.2 in 2008 to 269.8 in 
2011 and subsequently decreased to 261.5 in 2012. 
These increases in incidence and prevalence may be 
explained by an increase in problematic alcohol use in the 
population, an increase in reporting to the NDTRS, or a 
combination of both factors.
Almost one in five of those treated for problem alcohol use 
in 2012 also reported using at least one other substance, 
a similar proportion to that observed in previous years. In 
2012, the most common additional drugs used by treated 
alcohol cases were cannabis, cocaine, benzodiazepines and 
ecstasy. This ranking reflects a minor change since 2008, 
when opiates were the fourth most common additional drug. 
Use of more than one substance increases the complexity 
of cases and leads to poorer outcomes for the patient. 
Information about combinations of substances used is 
important in terms of individual clients’ care plans.
The median age at which both new and previously treated 
cases began drinking was 16 years. This has not changed 
for five years (2008–2012). The median age for all treated 
cases in 2012 was 40 years. The majority of those treated for 
problem alcohol use were male. The proportion of cases in 
employment decreased from 30% in 2008 to 20% in 2012.
(Anne Marie Carew)
 
1. Health Research Board (2014) Treated problem alcohol use 
in Ireland: figures for 2012 from the National Drug Treatment 
Reporting System. Dublin: Health Research Board. Available at 
www.drugsandalcohol.ie/21518
Figure 1  Incidence and prevalence of treated problem alcohol use per 100,000 of the 15–64-year-old 
population (NDTRS 2008–2012; CSO 2012, 2013)
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Cocaine use in Ireland: 2010/11 survey 
results
The National Advisory Committee on 
Drugs and Alcohol recently published 
Bulletin 4 in a series of reports on 
the 2010/11 survey on drug use in 
the general population.1 The bulletin 
focuses on cocaine use in the adult 
population (15–64 years) and provides a 
profile of cocaine use. The final achieved 
sample was 5,134 in the Republic of 
Ireland. This represented a response rate 
of 60%. This article presents a summary 
of some of the main results.
Key findings
Lifetime cocaine use increased in 2010/11 when compared 
to 2006/7.2 The proportion of adults who reported using 
cocaine (including crack) at some point in their lives 
increased from 5% in 2006/7 to 7% in 2010/11 (Table 1). 
The proportion of young adults who reported using cocaine 
in their lifetime also increased, from 8% in 2006/7 to 9% in 
2010/11. As expected, more men reported using cocaine in 
their lifetime than women, 10% compared to 4%. However, 
the proportion of adults who reported using cocaine in 
the last year (recent use) remained stable between 2006/7 
and 2010/11 at just under 2% (Table 1). The proportion of 
young adults who reported using cocaine in the last year also 
remained stable at 3%.
The proportion of adults who reported using cocaine in the 
last month (current use) also remained unchanged between 
2006/7 and 2010/11 at less than 1%.
Of the 5,134 survey respondents, 7% had used cocaine 
powder; crack cocaine use was rarely reported (0.6%). Half of 
all cocaine powder users commenced cocaine use before they 
were 21 years old, while half of all crack users commenced 
before they were 23 years old. Since 2006/7 there has been 
no change in the median age at which either cocaine powder 
or crack cocaine use commenced. 
Of the 26 current cocaine powder users, 95.5% used  
cocaine less than once per week, while 4.5% used it at least 
once per week. The majority of the current cocaine powder 
users (95%) reported snorting the drug, while the remaining 
5% reported smoking it. No other form of cocaine use  
was reported. 
Of the 76 recent cocaine powder users, only 4% obtained 
their cocaine from a person who was not known to them. 
Cocaine powder was most commonly obtained at the home 
of a friend (39%) or at a disco, bar or club (37%). The 
majority (70%) of recent cocaine powder users said that it 
was easy to obtain within a 24-hour period. 
Of the 75 self-defined ‘regular’ cocaine powder users, 83% 
had successfully stopped taking cocaine. The most common 
reasons for discontinuing were: did not want to continue 
using it (18%), could no longer afford it (17%), concerns 
about its health effects (15%), pros did not outweigh the 
cons (14%), and no longer part of social life (13%).
Trying cocaine once or twice was perceived as a ‘great 
risk’ by 74% of those surveyed. This perception of risk was 
particularly marked (at 78%) among those who had never 
tried cocaine, compared to that of lifetime users at (30%).
Variation in cocaine prevalence was analysed by a number 
of socio-economic indicators (social class, work status and 
age ceased education) none of which proved statistically 
significant. However, renting from a private landlord, having a 
third-level education and co-habiting were all associated with 
a significantly higher prevalence of lifetime cocaine use. 
The findings of this survey should be interpreted with care in 
view of the small number of responses on which the patterns 
of cocaine use are based. The socially excluded population 
is unlikely to be represented in a general population survey 
of this kind; its members may not live at a fixed address or, if 
listed, may be difficult to locate for interview. 
(Margaret Curtin)
1. National Advisory Committee on Drugs and Alcohol, and 
Drug and Alcohol Information and Research Unit (2014) Drug 
use in Ireland and Northern Ireland. 2010/11 drug prevalence 
survey: cocaine results. Bulletin 4. Dublin: NACDA and DAIRU. 
www.drugsandalcohol.ie/21727
2.  National Advisory Committee on Drugs, and Public Health 
Information and Research Branch (2008) Drug use in Ireland 
and Northern Ireland. 2006/2007 drug prevalence survey: 
cocaine results. Bulletin 4. Dublin: NACD and PHIRB. www.
drugsandalcohol.ie/11528
Cocaine  
use
Adults
15–64 years
%
Males
15–64 years
%
Females
15–64 years
%
Young adults
15–34 years
%
2002/3 2006/7 2010/11 2002/3 2006/7 2010/11 2002/3 2006/7 2010/11 2002/3 2006/7 2010/11
Lifetime 3.0 5.3 6.8 4.3 7.0 9.9 1.6 3.5 3.8 4.7 8.2 9.4
Last year 1.1 1.7 1.5 1.7 2.3 2.3 0.5 1.0 0.7 2.0 3.1 2.8
Last month 0.3 0.5 0.5 0.7 0.8 0.8 0.0 0.2 0.3 0.7 1.0 1.0
Table 1  Prevalence of cocaine use (including crack) in Ireland, 2002/3, 2006/7 and 2010/111,2
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Is the role of alcohol in accidental 
deaths under-reported in Ireland?
Media coverage of alcohol policy and alcohol-related issues 
generally falls into two categories. Thematic coverage deals 
with statistical facts and the effects of alcohol on society and 
the individual, while episodic reporting is a news story that 
reports on the person and their circumstances. It appears 
that most media coverage of alcohol-related risk is episodic 
and tends not to address the role of alcohol in the incident. 
Accurate reporting of alcohol-related deaths can improve 
support for public health messages among the general public 
by raising concern and awareness of the risks related to 
harmful alcohol use.
A recent study aimed to investigate whether the role of 
alcohol in accidental deaths was under-reported in Irish print 
media.1 Data from the National Drug-Related Deaths Index 
for the years 2008 and 2009 were used to identify deaths 
due to alcohol poisoning and deaths due to trauma (e.g. 
drownings, falls) in which alcohol was also mentioned on 
the death certificate. Deaths due to suicide or to chronic 
alcohol-related medical conditions were excluded. There 
were 388 deaths which met the inclusion criteria. An internet 
search was then conducted to locate local or national 
newspaper reports of those deaths. The content of the article 
was analysed, including any direct or indirect reference 
to alcohol use, using a hierarchical coding system. Media 
reports (excluding online funeral notices) were located for 
only 11% of the deaths. The authors note the limitation that 
an internet-based search alone is likely to have missed articles 
that had not been put on line. 
The study found that deaths due to alcohol poisoning were 
significantly less likely than traumatic deaths to be reported 
by the media, even though they represented the majority 
of deaths identified. When such deaths were reported, the 
method of death was never stated. While choking was the 
second most common cause of death in the inclusion group, 
no newspaper reports of these deaths were found. Reasons 
suggested by the authors for the under-reporting of the 
role of alcohol in poisoning and traumatic deaths included: 
the need for a post-mortem in some cases, a reluctance by 
journalists/editorial policy to speculate on the role of alcohol 
in the death, or a cultural reluctance to speak ill of the dead. 
The authors conclude that the role of alcohol in alcohol-
related deaths is under-reported in the Irish media and that 
an opportunity to inform the public of the consequences of 
harmful alcohol use is therefore missed. They recommend 
that journalists more proactively report on the role of 
alcohol in deaths, which would enable the public to make 
more informed decisions in relation to risks round their own 
drinking, and also in relation to their understanding and 
support of alcohol harm-reducing strategies, for example the 
recent Public Health (Alcohol) Bill.2
(Suzi Lyons)
1. Fagan J, Lyons S and Smyth B (2014) Content analysis of 
newspaper reports on alcohol-related deaths. Alcohol and 
Alcoholism. Published online 15 April 2014. doi: 10.1093/
alcalc/agu015. www.drugsandalcohol.ie/21799
2. Department of Health (2013, 24 October) Minimum unit 
pricing and regulation of advertising and sponsorship to be 
provided for in a Public Health Bill. Press release issued by 
the Department of Health on the announcement of the 
proposed Bill. www.drugsandalcohol.ie/20793
How alcohol can harm others besides 
the drinker
The burden of 
alcohol-related harm 
is often experienced 
by those around the 
drinker, including 
family members, co-
workers and innocent 
bystanders. The 
types of harm can 
include injury, neglect, 
property damage and 
public disturbances. 
The Health Service 
Executive (HSE) has 
published a report 
on the extent of this 
harm in Ireland.1 
The report examined 
alcohol harm to 
people other than 
the drinker in three settings – the general population, the 
workplace, and children in families – using survey data 
from two national drinking surveys conducted in 2006 and 
2010. Both surveys had a national representative quota 
sample of approximately 1,000 adults who were interviewed 
face-to-face. For the purposes of the study reported here, 
data from the two surveys were combined to give a total of 
2,011 respondents.
Harm to others in the general population
Over one in four people (28%) reported experiencing at 
least one negative consequence (family problems, being a 
passenger with a drunk driver, assault, property damage or 
money problems) as a result of someone else’s drinking.  
The people most likely to experience these harms were  
those aged under 50 years, those from a lower social class 
and those who engaged in regular risky drinking. Women 
were most likely to report family problems (16%), while 
males aged 18–29 years were most likely to experience 
assault (21%). 
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Harm to others in the workplace
One in ten (10%) Irish workers experienced at least one 
work-related harm; the harms were ability to do job 
negatively affected, having to work extra hours, and 
accidents or close-calls at work. Overall, men (14%) and 
18–29-year-olds (16%) were most likely to experience harms 
as a result of their co-workers’ drinking. The overall reported 
rate of harm in the Irish workforce was double that reported 
in a similar Australian study.
Harm to children
One in ten adults reported that children for whom they had 
parental responsibility experienced one or more harms as a 
result of someone else’s drinking. The harms were: being left 
in unsafe situations, experiencing verbal abuse, experiencing 
physical abuse, or being witness to serious violence in the 
home. Parents who were regular risky drinkers were more 
likely to report that children experienced at least one harm 
(13%). Higher rates of children witnessing serious violence 
in the home as a result of others’ drinking were reported by 
parents from the lower social class.
Conclusion
It is clear that alcohol’s harm to others is far reaching and 
can be serious. It causes significant damage across Irish 
society and its impact is more extensive than that reported 
in similar research in Canada and Australia. The author 
states that there is a need for ‘a dedicated study specific to 
alcohol’s harm to others’ as suggested by the World Health 
Organization, to establish the scope and size of the problem, 
its impact on health and social services usage, as well as the 
burden and cost to Irish society. 
(Deirdre Mongan)
1. Hope A (2014) Alcohol’s harm to others in Ireland. Dublin: 
Health Service Executive. www.drugsandalcohol.ie/21590
Alcohol harm to others (continued)
Alcohol Forum conference – alcohol’s 
harm to others
As part of National Alcohol Awareness Week, the Alcohol 
Forum held a conference entitled Alcohol’s harm to others: 
when their drinking becomes your problem in the Convention 
Centre, Dublin, on 2 April 2014. Minister of State Alex White 
TD delivered the opening address. He spoke about the 
damaging impact of alcohol on the family, the workplace, 
and society as a whole and said that reducing alcohol 
consumption in Ireland is not just a task for government, 
but that it is also an issue where local communities can 
take a lead. He assured the audience that the government 
is committed to tackling alcohol misuse in Ireland and 
that the Public Health (Alcohol) Bill is being drafted in the 
Department of Health. He said that the conflicting interests 
of the drinks industry which seeks to increase alcohol 
consumption and public health professionals who seek to 
reduce alcohol consumption cannot be reconciled when it 
comes to formulating public health policy. He also said that 
the alcohol industry seeks a role for itself in public health  
policy areas that extends far beyond its role as producers  
and retailers of alcohol. 
Professor Robin Room of the University of Melbourne, and 
advisor to the World Health Organization, described the 
results of research he had undertaken in Australia which 
measured the range and magnitude of alcohol’s harm to 
others. Professor Moira Plant, University of the West of 
England, Bristol, described the harms caused by maternal 
alcohol consumption during pregnancy and the damage it 
can cause to the developing foetus. She also described the 
signs and symptoms of foetal alcohol spectrum disorder, and 
the impact it can have throughout a person’s life. Dr Helen 
McMonagle, rehabilitation co-ordinator with the Alcohol 
Forum, spoke about alcohol-related brain injury (ARBI) and 
its impact on the family and society.
Mr Joe Doyle, HSE National Planning Specialist, outlined how 
the HSE will respond to the specific recommendations in the 
Steering group report on a National Substance Misuse Strategy 
relating to the HSE. Dr Ann Hope, Trinity College Dublin, 
described the main findings of a recent Irish report which 
indicate that alcohol’s harm to others is extensive in Ireland 
(see article on that report elsewhere in this issue). Dr Michael 
Byrne, University College Cork, described initiatives that the 
university has undertaken in recent years to tackle alcohol-
related harm among the university’s students.
The presentations may be viewed at www.drugs.ie/
multimedia. 
(Deirdre Mongan)
Professor Robin Room 
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Alcohol and mental health among 
school students
Alcohol can contribute to the development of mental health 
problems as well as exacerbating pre-existing mental health 
difficulties. A recent Irish report, Alcohol and youth mental 
health – the evidence base,1 profiled drinking behaviour 
and psychological health in 6,085 12–19-year-olds in 
72 randomly selected post-primary schools in Ireland to 
determine the association between drinking behaviour and 
mental health and to identify risk and protective factors 
associated with adolescent drinking. Participants completed 
the My World Survey – Second Level (MWS–SL), which 
contains a battery of psychometrically reliable instruments 
assessing risk and protective factors of psychological health.
Alcohol consumption among students
Overall, 49% reported never drinking alcohol, while 22% 
drank alcohol less than once a month, 18% drank alcohol 
monthly and a further 10% drank alcohol weekly. Alcohol 
consumption increased as students progressed through 
school; 83% of first-year students were non-drinkers, 
compared to 9% of sixth-years. Patterns for males and 
females were broadly similar. The typical volume of alcohol 
consumed per drinking occasion among 1st, 2nd and 3rd 
years was 1–2 drinks. Among 4th years, 38% consumed 
3–4 drinks, while 69% of 6th years consumed at least five 
drinks, with 14% consuming 10 or more drinks on a typical 
drinking occasion. This steady progression was most evident 
among females. Binge drinking was defined as six or more 
standard drinks on a single drinking occasion. Overall, 30% 
reported never binge drinking, with rates ranging from 63% 
of 1st years and 10% of 6th years. According to the AUDIT 
(Alcohol Use Disorders Identification Test) criteria, 10% of 
junior cycle students and 35% of senior cycle students had a 
harmful pattern of drinking.
Alcohol and mental health
On the Depression, Anxiety and Stress Scale (DASS), 11% 
displayed mild levels of depression, 11% displayed moderate 
levels, 4% severe levels and 4% very severe levels. A strong 
association was observed between harmful drinking and 
severity of depression. Among junior cycle students, 2% 
were classified as possibly being alcohol dependent and 
12% of these as having severe depression. Similar patterns 
were observed for those in the senior cycle, and the patterns 
observed for depression were also evident for anxiety and 
stress. Protective factors such as personal competence, family 
cohesion and life satisfaction were significantly related to 
alcohol behaviour; those with harmful drinking patterns had 
lower levels of these protective factors than those who did 
not drink in a harmful manner. 
Conclusions
The results indicate that alcohol consumption among 
adolescents is associated with mental difficulties and the 
authors conclude that addressing alcohol behaviour may 
reduce the risk of mental health difficulties and may also 
increase protective factors. They state that this will require a 
multi-faceted approach involving parents, schools and the 
wider community and that international research suggests 
that key interventions include school strategies focusing 
on strengthening personal and social protective factors; 
family approaches such as increasing family cohesion; and 
community strategies such as reducing alcohol availability 
through regulation. 
(Deirdre Mongan)
1. Fitzgerald A and Dooley B (2013) Alcohol and youth mental 
health – the evidence base. Psychiatry Professional, 2(1): 6–8.  
www.drugsandalcohol.ie/21265
How attitudes to alcohol affect 
judgements about sexual behaviour
The Rape Crisis Network Ireland 
commissioned NUI Galway 
to undertake a qualitative 
study to explore university 
students’ attitudes to alcohol 
use and consent to engage in 
sexual activity1 and to build on 
previous Irish research,2 which 
demonstrated a high rate of 
co-occurrence of rape and heavy 
drinking by perpetrators and/
or victims. A total of 187 young 
adults in an Irish university took 
part in the study; four focus groups 
were held with 24 females, three focus groups were held 
with 20 males, and an online survey using open-ended 
questions was completed by 143 students.
The context for consent – alcohol’s role in 
student life
Analysis of the focus groups’ data revealed that alcohol 
plays a key role in students’ social interactions. It acts as an 
icebreaker, gives confidence, helps to overcome shyness, and 
helps students to form friendships. Drinking is the norm and 
students fear exclusion from their peer group if they do not 
join in and drink. Regarding sexuality, alcohol is perceived by 
students to be an enabler, which helps them to approach a 
person of the opposite sex. Alcohol provides ‘Dutch courage’ 
and is often the main reason that a couple get together. 
Consent to sex: reading implicit signs
Consenting to sex was described as being largely implicit; 
consent is usually given through non-verbal signs, rather 
than verbally. In general, males increase the extent of 
physical intimacy until the female indicates that she wants 
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Alcohol and sexual behaviour (continued)
the male to stop. Hook-up encounters present problems 
regarding consent as the two individuals have not built up 
any trust with each other. In these circumstances, body 
language and flirting were considered to indicate consent. 
One of the male focus groups stated that ‘most lads will 
know if she’s up for it’, and if a partner agreed to leave the 
nightclub with you, this could be interpreted as a clear sign 
of interest in sex.
Alcohol had an impact on both the provision and 
understanding of consent. Providing consent if one or both 
of the partners were drunk was difficult, especially during 
hook-up encounters, which were more likely to occur when 
alcohol was consumed. The students stated that in these 
situations alcohol made it more likely that consent would 
be assumed rather than being explicitly provided verbally. 
A problematic issue was determining if one partner was 
drunk beyond the point of giving consent. The threshold the 
students identified for being unable to give consent could be 
considered as high. Males said that a female was able to give 
consent ‘as long as she could talk’. However, if one partner 
was a lot drunker than the other, the less drunk person could 
be at risk of ‘taking advantage’ of the other person. It was 
considered wrong to have sex with someone whose ability to 
provide consent was less effective than your own. 
Alcohol and sexual assault
Both male and female focus group participants clearly believe 
that sexual assault is wrong and that it has serious and long-
lasting consequences for victims. There was consensus that 
it is important not to blame the victim when sexual assaults 
occur. Alcohol plays an important role in sexual assaults; it 
lowers inhibitions, which in turn leads to loss of control; it 
can cause males to lose their ability to regulate their drive for 
sex; it can make women lose their ability to refuse sex; and 
it can remove a victim’s ability to report what has happened. 
There was also a belief that alcohol consumption can 
undermine a victim’s credibility when it comes to reporting a 
rape or assault. 
Analysis of the online survey found that the responses were 
consistent with those made by focus group participants. 
Conclusions
The authors recommend supporting ‘systematic, 
communication-based approaches’, to change current 
attitudes to alcohol and non-consenting sexual activity, 
and they state that approaches are required to enable 
young people to understand the meaning of consent. 
They conclude that ‘young people should be regarded as 
partners to health professionals, peer educators, and others 
in achieving change in the status quo. The use of active, 
stimulating methods of engagement should help youth 
move from principles to practice in their critical thinking 
about consent’. 
(Deirdre Mongan) 
1. MacNeela P, Conway T, Kavanagh S et al. (2014) Young 
people, alcohol and sex: what’s consent got to do with it? 
Exploring how attitudes to alcohol impact on judgements about 
consent to sexual activity: a qualitative study of university 
students. Galway: Rape Crisis Network Ireland. www.
drugsandalcohol.ie/21286
2. Hanly C, Healy D and Scriver S (2009) Rape and justice In 
Ireland: a national study of survivor, prosecutor and court 
responses to rape. Dublin: The Liffey Press. www.rcni.ie/wp-
content/uploads/Exec-Summary.pdf
Forced labour and the drug trade
Forced labour in the production of cannabis is the subject 
of a research report by the Migrant Rights Centre Ireland 
(MRCI).1 According to MRCI, this phenomenon involves 
human trafficking for the purpose of criminal exploitation. 
The study examined trafficking for cannabis production 
‘specifically focusing on cases and reports where Vietnamese 
and Chinese nationals were involved’ (p.1). The research 
is part of a wider European study led by the Anti-Slavery 
International (ASI) Race in Europe project. ASI has identified a 
trend in victims being trafficked from Vietnam to Ireland via 
the UK in recent years.
In Ireland, human trafficking for criminal exploitation has 
only recently been criminalised, under the Criminal Law 
(Human Trafficking) (Amendment) Act 2013. Consequently, 
there is limited available data on the effect of the legislation. 
The MRCI study involved semi-structured interviews with 
members of the legal profession, the Anti-Human Trafficking 
Unit (AHTU) of the Department of Justice and Equality which 
was established in 2008, the Human Trafficking Investigation 
and Co-ordination unit within An Garda Síochána, 
established in 2009, and the Chaplain Service at Mountjoy 
prison. An analysis of media articles and press releases was 
also conducted and a number of case studies are presented 
in the MRCI report.
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The report highlights the increase in domestic cannabis 
cultivation in Ireland in the last five years, noting the 
dismantling of 500 cannabis cultivation sites by the gardaí 
during 2011. It refers to a recent EU drug market study 
by the European Monitoring Centre for Drugs and Drug 
Addiction and Europol which reported the involvement of 
Vietnamese and Chinese organised crime groups (OCGs) 
in cannabis cultivation in Ireland.2 According to the MRCI, 
there were 80 people of Asian origin in Irish prisons in 
2013 for drug-related offences, with 50 of these in custody 
for cannabis cultivation. The report refers to numerous 
newspaper and online media articles about cases involving 
Vietnamese and Chinese nationals, and presents two MRCI 
case studies, which are abridged below.
Mr W was offered the opportunity to move to Ireland 
from the UK, where he had been paid below the 
minimum wage for a number of years. He was offered 
work in a Chinese restaurant as a porter. On arrival in 
Ireland, he was taken to a small house in a rural location. 
He was told to water the plants in the house and that, if 
he tried to escape, he would be killed by the recruiter’s 
boss, who was Irish. W escaped and contacted An Garda 
Síochána. He was hospitalised for a number of days 
suffering from exposure. He was then arrested on drugs 
charges and later imprisoned. The courts requested An 
Garda Síochána to conduct an assessment of human 
trafficking. Trafficking was not identified by the relevant 
Garda in this case.
Mr B, a Vietnamese national was offered a job in Ireland 
as a gardener. He was smuggled out of Asia and ended 
up in an industrial estate in rural Ireland. He was locked 
in a barn and ordered to look after hundreds of plants 
and control the hoses, lights and heaters. He slept on a 
mattress and was brought food once per week. He had 
no idea what country he was in, but he knew he was 
minding a cannabis factory. When police located the 
barn, they found B locked inside. Through an interpreter 
he told them he had been kept as a slave, forced to 
tend to the plants and threatened with violence. He told 
them he had received no money. B was charged with 
possession of the plants and faces a mandatory minimum 
ten-year prison sentence.
The report states that, ‘out of all the Vietnamese nationals 
who have been arrested and charged with cannabis 
cultivation since 2010, no cases of trafficking for forced 
labour have been identified by an Garda Síochána’ (p.5). 
As a consequence, ‘potential victims are being prosecuted, 
convicted and imprisoned for crimes they may have been 
forced to commit – while their traffickers enjoy impunity’ 
(p.5). MRCI argues that the inability of An Garda Síochána  
to identify victims in such circumstances has created the 
need for such victims to be ‘formally identified’ by an agency 
like the Health Service Executive, with the co-operation of 
MRCI, so that victims can receive the care and attention  
they require. 
Included among the other recommendations of the study are 
the following:
 ■  All cases of potential trafficking for forced labour in 
cannabis production should be investigated for human 
trafficking by An Garda Síochána.
 ■  An independent national rapporteur should be appointed 
by the government to identify trends in human 
trafficking and address problems of lack of identification 
and prosecution.
 ■  Victims should be provided with a reflection and recovery 
period, safe accommodation, health care, counselling 
and financial supports where they have been identified as 
a suspected victim of human trafficking.
 ■  Training needs to be provided by ASI and MRCI for 
investigators, prosecutors, judiciary, and the legal 
profession to equip them with the skills to identify such 
potential victims.
 ■  A non-punishment clause should be included in the 
Criminal Law (Human Trafficking) Act 2008 to ensure 
that victims of trafficking are exempt from prosecution 
for offences that they were forced to commit.
MRCI intends to conduct further research in this area in the 
future as more information becomes available.
(Johnny Connolly)
1. Migrant Rights Centre Ireland (2014) Trafficking for forced 
labour in cannabis production: the case of Ireland. Dublin: 
MRCI. www.drugsandalcohol.ie/21642
2. European Monitoring Centre for Drugs and Drug Addiction, 
Europol (2013) EU drug markets report: a strategic analysis. 
Luxembourg: Publications Office of the European Union. 
www.drugsandalcohol.ie/19227. For a review of this study, 
see Connolly J (2013) EU drug markets – a strategic analysis. 
Drugnet Ireland, (45): 8–9.
Forced labour and the drug trade (continued)
21
drugnet 
Ireland
Preventing and responding to overdose 
in homeless accommodation in Limerick
The voluntary agency Novas 
Initiatives is the largest provider of 
homeless accommodation in the 
Mid-West area. McGarry House 
was opened by Novas in 2002 in 
Limerick city and provides homeless 
accommodation for 30 individuals 
and long-term supported housing 
for 37 individuals. In recent years 
the staff have observed a change 
in the profile of their residents, 
with escalating and more chaotic 
drug use: between May 2012 and November 2013 the staff 
responded to 34 overdose incidents. 
In response to this, Novas commissioned a research project 
in order to gain a better understanding of the problem of 
overdose in McGarry House and to assess their responses 
to such incidents.1 The aim of the research was to: 1) 
understand the experience of overdose among residents 
and staff; 2) understand the risk-taking behaviour of the 
residents; and 3) identify ways to improve knowledge 
and reduce the risk of overdose and increase effective 
bystander response.
A mixture of qualitative and quantitative methods was used: 
semi-structured interviews with 15 staff and 15 residents; an 
on-line survey of 20 staff; a postal survey of four GPs; focus 
groups with staff, residents and professional stakeholders; 
and a systems review of the policies and procedures. The 
small sample size was identified as a limitation by the 
authors, with 50% of residents, nine key stakeholders 
and four (out of the 15 GPs invited) taking part in the 
research. Recall bias may also have been an issue in the 
case of participants who may have used drugs, particularly 
benzodiazepines, which can affect memory.
Profile of residents
Of the 114 people who lived for a time in McGarry House 
in the course of 2012, 11% were aged under 21 years, and 
almost half (48%) were aged under 30 years. The percentage 
of residents presenting with drug use issues had risen from 
17% in 2010 to 27% in 2012. 
Of the 15 residents who participated in the study, almost 
all had an extensive history of both illicit drug use (heroin, 
street methadone, crack cocaine, street benzodiazepines 
and Z-drugs, novel psychoactive drugs) and licit drug use 
(alcohol, prescribed methadone, benzodiazepines and 
Z drugs). Over half (8, 58%) reported that they injected 
frequently. 
Experience of overdose:
 ■  73% (11) had ever overdosed.
 ■  93% (14) had witnessed another person overdosing  
in the past year.
 ■  85% (17) of staff had been on shift when an  
overdose occurred.
 
 
Of those who overdosed:
 ■  100% (11) had overdosed in the past year.
 ■  91% (10) reported benzodiazepines as the most 
common drug involved in their overdose. 
 ■  82% (9) had overdosed more than once.
 ■  82% (9) reported heroin involvement in their overdose. 
 ■  72% (8) of overdoses involved more than one drug.
 ■  64% (7) were with someone when they overdosed.
 ■  46% (5) reported alcohol involvement in their overdose.
 ■  36% (4) had overdosed in the six months prior to  
the interview.
One of the themes to come from the study was that, 
while residents were at high risk of overdose, participants 
expressed ambivalence about the extent of their risk. Of 
those who discussed this, many felt it was unlikely that they 
would overdose again, or were not concerned about the risk 
or worried about overdosing. This was despite the fact that 
over half of residents interviewed felt that overdose was an 
inevitable or unavoidable part of drug use. Almost all agreed 
that they could reduce their overdose risk; however, the 
perceived degree of difficulty in doing this varied between 
residents. 
Of the residents who had witnessed an overdose, the 
majority reported carrying out appropriate emergency 
responses, e.g. checking level of consciousness, breathing 
and pulse. However, some reported carrying out 
interventions which were not effective or potentially harmful: 
walking the person around (risk of fall and injury); putting 
the person in the bath (risk of drowning); and injecting 
with salt water. Four participants stated that they were 
concerned about calling an ambulance for fear of personal 
consequences if the gardaí also arrived.
More than half of the residents interviewed felt that they 
knew ‘very little’ or ‘some’ about the causes of overdose, but 
87% were interested in taking part in overdose prevention 
training, including provision of naloxone.
The researchers also noted that while McGarry House 
promoted a low-threshold ethos, e.g. by providing safe 
disposal bins for needles, some residents still worried about 
negative consequences if they disclosed their drug use.
Another theme emerging from the research related to 
interagency prevention and response. The external agencies 
acknowledged the vital role of McGarry House in overdose 
prevention and were keen to develop interagency protocols 
and structures. At the time of the research, Novas was working 
with the HSE to improve interagency co-ordination, with a 
focus on providing clarity around maintaining confidentiality 
while striving to prevent overdose. Another example of 
interagency work was liaison with the ambulance service in 
order to speed up processes and improve communication. 
Two themes emerged in relation to the challenges McGarry 
House staff faced in responding to overdose. While there 
was very much a ‘coping culture’ there was a need to ensure 
effective support for staff, and for further development of 
confidence, capacity and learning opportunities.
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One of the particular issues raised by staff concerned 
pregnant women who had continued to use drugs, some 
intravenously, during their pregnancies (in the period before 
the research was conducted). The staff reported this as 
extremely stressful (indeed, one woman had given birth in 
the hostel) and, while pregnancy does not increase the risk of 
overdose, the consequences of any overdose has implications 
for both the woman and her unborn child.
The recommendations made in the report are 
summarised below.
 ■  Develop a peer education programme for residents on 
understanding risks, prevention and management of 
overdose. 
 ■  Provide consistent harm reduction information that is 
agreed at an interagency level.
 ■  Update overdose policy which can be reviewed as 
required. Review the client risk assessment form.
 ■  Train staff in additional effective overdose prevention 
interventions, e.g. motivational interviewing and 
cognitive behavioural therapy to address the ambivalence 
to overdose risk expressed by some clients.
 ■  Continue to work to, and promote with residents, an 
evidence-based low-threshold approach.
 ■  Clearly communicate to residents that their personal 
information is treated confidentially and only shared for 
risk management.
 ■  In consultation with staff, develop and provide 
appropriate supports to staff in the event of an overdose.
 ■  Explore, with other agencies, the opportunities for a 
naloxone distribution programme.
 ■  Develop and formalise interagency protocols to improve 
communication and information sharing in relation 
to overdose, with the HSE and emergency services in 
particular. 
 ■  Develop person-centred assessment training in 
collaboration with the Homeless Persons Centre in 
Limerick city to improve information gathering of risk 
factors from residents. 
 ■  Improve understanding with GPs and pharmacists by 
developing a standard information letter which explains 
the role of McGarry House in overdose prevention.
 ■  Support the development of an interagency response 
to care for pregnant women who use drugs, e.g. 
employment of a regional drug-liaison midwife.
(Suzi Lyons)
1. Dermody A, Gardner C, Quigley M and Cullen W (2013) 
Heads up: preventing and responding to overdose in McGarry 
House, Novas. Limerick: Novas Initiatives.  
www.drugsandalcohol.ie/22183
Forensic Science Laboratory analyses 
street-level heroin and cocaine
An analysis of heroin and cocaine seizures submitted to the 
Forensic Science Laboratory (FSL) between April 2010 and 
March 2012 sought to assess the current status of these 
particular drug markets, ‘in order to track changes in the 
markets, and for comparison to reported European data’.1 
The study also sought to establish whether purity plays a role 
in the pricing of street drugs. This is particularly important 
in the Irish context as, under the terms of Section 15a of 
the Criminal Justice Act 1999 (as amended), a mandatory 
minimum sentence of 10 years applies where a person is 
convicted of possession of drugs with a market value of 
€13,000 or more. For the purposes of this legislation, the 
market value is interpreted as the maximum value a drug 
could realistically be expected to obtain at street level when 
purchased by an end user. 
Street-level purity data give an indication of the purity of 
the substance reaching the end user. Unlike markets for 
legitimate goods, in the illicit drug trade the quality of the 
commodity is not regulated or guaranteed and therefore 
is something than can only be assessed by the user after 
consumption. As a consequence, just like restaurant meals or 
used cars, illicit drugs are referred to as ‘experience goods’, 
as their quality is only fully knowable after use.2 A further 
complicating factor is that adulterants are added to drugs 
not only to bulk them up for sale but also to enhance or 
mimic the effects of the drug for the user. So, for example, 
where a user might believe the drugs s/he consumes are of a 
good quality, this does not necessarily mean that they are of 
a higher purity.3 
In the FSL study, quantitative analysis to determine drug 
purity was carried out on randomly selected street-level 
seizures on a monthly basis during the two-year period of the 
study. Data were also collected on the type and frequency of 
adulterants detected in the seizures. Price information for a 
subset of the cases quantified and also for a number of cases 
not quantified was obtained from An Garda Síochána. 
Responding to overdose among the homeless (continued)
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Findings in relation to heroin seizures
Analysis conducted by the FSL as part of a National Advisory 
Committee on Drugs and Alcohol/Health Research Board 
(NACDA/HRB) study of illicit drug markets in Ireland found 
an average heroin purity of 45% in a sample of 131 heroin 
seizures from four distinct markets in 2008/2009.4 In the 
current study, in a sample of 239 diamorphine (heroin) 
cases the mean purity was 47% for 2010, 30% for 2011 and 
24% for the first three months of 2012. The study reveals ‘a 
general decline of diamorphine purity over the time period, 
with the 2012 average being nearly half the average purity 
obtained for 2010’ (p.2).
Of the 239 heroin samples analysed, 81% contained 
adulterants/dilutants. The frequency of detected adulterants 
increased from 67% of cases in 2010 to 100% in 2012. This 
may help explain the drop in purity during the same period as 
it was also found that ‘the mean purity of heroin samples with 
no detected adulterants was 58%, whereas the mean purity…
containing adulterants was 31%’ (p.2). The main adulterants 
found were caffeine and paracetamol, usually together. 
Coomber (2006), in a discussion of drug adulteration,  
points out that one of the reasons caffeine is commonly 
found with heroin is that, when heroin is smoked or ‘chased’, 
caffeine has been shown ‘to enable a higher amount of the 
heroin (around 76%) to be recovered (i.e. the amount of 
heroin left available in the ‘smoke’ which is inhaled), after 
volatization (the heating, melting and then vaporization of 
the drug for inhalation or ‘chasing’) than when compared 
to pure heroin alone’.5 Heroin is also commonly adulterated 
with paracetamol because the latter has approximately the 
same melting point as heroin and also has analgesic (pain-
killing) properties. 
The Garda National Drugs Unit (GNDU) provided price 
data for 144 street-level heroin cases submitted to the FSL 
between 2010 and 2011. The powder weights for these 
packs ranged from 0.097g to 1.862g, with an average  
price per gram of €116.71. The most frequent street-pack 
prices were €20, €25 and €50. There was a correlation 
between pack sizes and prices, leading the authors to 
conclude that ‘the driving factor for diamorphine prices  
may not be perceived quality, but perhaps the quantity 
of drug sold, or customer demand in times of limited 
diamorphine supply’ (p.3).
Findings in relation to cocaine seizures
In the NACDA/HRB study referred to above, a forensic 
analysis of 93 samples of cocaine found that purity levels 
were generally very low, averaging 14% across the four 
local drug markets studied. The current study, where purity 
was determined for 217 cocaine cases over the 2010–2012 
period, made a similar finding, with the average purity 
remaining fairly stable, at 15% for 2010, 19% for 2011 
and 17% for the first three months of 2012. The study 
also recorded a larger degree of variation in the purities of 
cocaine samples when compared to those for diamorphine. 
Ninety-nine per cent of samples contained one or more 
adulterants, with the main ones being lignocaine, levamisole, 
phenacetin, caffeine and benzocaine. According to Coomber 
(2006), referring to similar findings from research on the UK 
drug market, given that these are all substances that have 
either analgesic and/or stimulant properties, this shows the 
‘purposive nature of such cutting’, or adulteration.6 Pricing 
data were obtained from the GNDU for 17 cocaine seizures 
for which purity was determined during the study period but 
no correlation was found between price and purity.  
When the findings of the study for 2010 were compared to 
similar data compiled by the European Monitoring Centre 
for Drugs and Drug Addiction (EMCDDA), it was found that 
Ireland’s mean purity of diamorphine was the second highest 
after Turkey and that it ranked the third most expensive after 
Sweden and Latvia. With regard to cocaine data for 2010, it 
was found that the mean purity of cocaine in Ireland was the 
lowest reported to the EMCDDA, while the price per gram 
was the second highest after Luxembourg.
The compilation and reporting of drug purity trend data in 
studies such as this can enhance our understanding of illicit 
drug markets and also the impact of drug law enforcement 
interventions on the behaviour of such markets. Studies such 
as this enable us to provide some context to changes in the 
behaviour of street-level drug markets. For example, it is 
worth speculating whether the decline in heroin purity since 
2010 identified in this study may be linked to the heroin 
drought of that year, and also whether the poor quality of 
heroin may have contributed to the rise in the street sale and 
use of benzodiazepines by opiate users in recent years.7 
Comprehensive chemical profiling of drug seizures can 
also indicate links between seizures in different locations, 
thereby providing intelligence on patterns of drug supply. 
Information on the types of adulterants used to bulk up 
drugs for street sale and/or to enhance their quality for the 
end user can provide important public health information. 
At present, however, the purity of drugs in Ireland is not 
routinely tested (quantified) due to the resource implications 
such an endeavour would entail. The development and 
reporting of indicators in the drug supply area such as 
seizures, price and purity data are currently a priority of  
the EMCDDA, in collaboration with Europol and the 
European Commission.8 
(Johnny Connolly)
1. Boyle M, Carroll L, Clarke K et al. (2014) What’s the deal? 
Trends in Irish street-level heroin and cocaine 2010–2012. 
Drug Testing and Analysis, Published online 24 March. DOI: 
10.1002/dta.1639. www.drugsandalcohol.ie/21608
2.  Reuter P and Caulkins J (2004) Illegal ‘lemons’: price 
dispersion in cocaine and heroin markets. Bulletin on 
Narcotics, LVI, (1 & 2) 141–165. New York: United 
Nations Publications. www.unodc.org/pdf/bulletin/
bulletin_2004_01_01_1_Art6.pdf
3.  For further discussion of the role of adulterants in drug 
markets see Coomber R (2006) Pusher myths: re-situating the 
drug user. London: Free Association Press.
4.  Connolly J and Donovan A (in press) Illicit drug markets in 
Ireland. Dublin: National Advisory Committee on Drugs and 
Alcohol, and Health Research Board. Some of the purity 
data from this study were reported in the following: Irish 
Focal Point (2011) 2011 National Report (2010 data) to 
the EMCDDA by the Reitox National Focal Point. Ireland: new 
developments, trends and in-depth information on selected 
issues. Dublin: Health Research Board.  
www.drugsandalcohol.ie/16812
5.  Coomber R (2006) p. 73.
6.  Coomber R (2006) p. 76.
7.  Irish Focal Point (2011) 2011 National Report (2010 data) to 
the EMCDDA by the Reitox National Focal Point. Ireland: new 
developments, trends and in-depth information on selected 
issues. Section 1.2, p.20. Dublin: Health Research Board. 
www.drugsandalcohol.ie/16812
8.  Connolly J (2011) First European conference on drug supply 
indicators. Drugnet Ireland, (36): 12.  
www.drugsandalcohol.ie/14696
FSL analyses heroin and cocaine (continued)
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AAI leaflet on alcohol and pregnancy
In March 2014 Alcohol Action 
Ireland produced an information 
leaflet in conjunction with the 
country’s three largest maternity 
hospitals, the National Maternity 
Hospital, the Rotunda Hospital 
and the Coombe Women & 
Infants University Hospital. 
Alcohol and Pregnancy1 warns of 
the dangers of drinking during 
pregnancy and advises that the 
optimal approach for pregnant 
women is to abstain completely 
from alcohol consumption.
Exposure to alcohol during 
pregnancy increases the risk 
of impairment of the physical 
and mental development of the 
unborn child. Alcohol passes through the placenta from the 
mother’s bloodstream to that of the child. An adult liver 
can break down a unit of alcohol in one hour. However, the 
underdeveloped liver of the unborn child does not have 
this capacity.
The effects of alcohol on the unborn child are manifold 
and may be expressed through a variety of mental and 
physical development issues with life-long consequences. In 
particular, the impact of alcohol can manifest in the form of 
Foetal Alcohol Syndrome (FAS) or Foetal Alcohol Spectrum 
Disorder (FASD).
FAS is caused by a high level of exposure to alcohol 
throughout pregnancy and results in growth retardation, 
facial defects and pronounced learning and behavioural 
difficulties. FASD refers to a spectrum of less pronounced  
but more common difficulties resulting from exposure to 
alcohol in the womb. Despite appearing healthy, children 
with FASD can experience a range of issues such as sight  
and hearing impairment, as well as social, cognitive and 
learning difficulties. 
Women who drink heavily during pregnancy are also at 
increased risk of complications, in particular, miscarriage, 
premature delivery and stillbirth.
The risk of impairment to the unborn child increases with 
the level of alcohol consumed. However, the exact level at 
which alcohol consumption becomes harmful is not known. 
As a result, women can receive conflicting advice. This leaflet 
advocates that since alcohol is a known toxic substance 
without a clearly defined level of safe consumption, it is best 
for pregnant women to abstain completely once they know 
that they are pregnant or are trying to conceive.
Pregnant women who are concerned about their alcohol 
consumption are advised to consult their health professional. 
They are encouraged to maintain a good support network 
during pregnancy, to ask their partner to also reduce their 
drinking, and to stay active. Meeting friends in a cafe rather 
than a bar, choosing fruit juices or non-alcoholic drinks, 
as well as eating healthily and not smoking or consuming 
harmful drugs, are also advocated.
(Margaret Curtin)
1.  Alcohol Action Ireland (2014) Alcohol and pregnancy.  
Dublin: AAI. www.drugsandalcohol.ie/21647
Barriers or bridges?
A CityWide consultation report 
on the impact of budgetary 
cuts on Drug Rehabilitation 
Projects (DRPs) has identified 
significant challenges for 
such projects in terms of 
maintaining their crucial 
work with recovering drug 
users.1 The report concludes 
that changes introduced to 
the Community Employment 
scheme in order to increase 
its focus on labour market 
activation have not taken into 
account the distinct role of DRPs. In particular, the research 
found that recent budgetary changes had led to a change in 
the profile of those applying for places on the projects. The 
major impact is ‘on the one hand, the fall in applications for 
places [on DRPs] from people who are on One Parent Family 
Payment or Disability payments and the increase  
in applications from people who are on Job Seekers  
Payment’ (p.30). 
As set up, DRPs were largely based on a model of working 
with people who were on methadone and attending clinics.  
They also provided a financial incentive for people parenting 
alone and for those in receipt of disability payments to 
address their addiction problems. Budget 2012, the report 
concludes, ‘wiped out’ this incentive. The majority of 
projects have seen a decrease in the number of women 
joining projects and ‘a spike in applications from younger 
men over the past two years; this younger cohort may never 
have used heroin, but use a cocktail of illegal drugs, tablets 
and alcohol. This provides a more challenging environment 
in which to deliver rehabilitation programmes’ (p.30).
Calling for a change in the way such projects are managed 
in the future, Anna Quigley, co-ordinator of CityWide, stated 
at the launch of this report: ‘We must address the issues 
identified in the report if we are to maintain and build on 
the achievements and successes of DRPs in our communities 
to date. The DRPs were set up and are operating as a core 
element of the National Drugs Strategy and an urgent 
review to address these issues should take place through the 
structures of the NDS led by Minister Alex White TD.’ 
1. CityWide Drugs Crisis Campaign (2014) Barriers or bridges? 
Drugs rehabilitation projects – the road to recovery. A 
CityWide consultation report. Dublin: CityWide. www.
drugsandalcohol.ie/21512. See also the two related videos  
at www.drugsandalcohol.ie/21589.
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The Talbot Centre celebrates 30 years  
of service
The Talbot Centre in Dublin’s north inner city is the longest 
established drug prevention and education service for 
children, young people and their families in Ireland. The 
centre celebrated its 30th anniversary in March 2014 with 
the launch of a special commemorative booklet, Thirty years 
of the Talbot Centre.1 
Services provided by the staff at the centre include support, 
advocacy, brief interventions, family work, substance/drug 
education, prison visits, family therapy, recreational activities, 
counselling, and education and training programmes for 
local community workers and school staff. 
The commemorative booklet, with contributions from service 
users and representatives from some of the many voluntary, 
community and statutory groups linked with the centre, 
reflects on the work of the centre since its inception, its key 
milestones and how it has evolved and reshaped its services 
to reflect the changing nature of drug use and behaviours of 
young people in the area.
Speaking at the anniversary event, the director general of the 
Health Service Executive, Tony O’Brien, said: 
The centre is a model of best practice as a drug 
prevention education project and plays a unique role 
within the HSE Addiction Service by providing support to 
young people with problems associated with substance 
misuse and family support for those living with individuals 
who have an addiction. Their preventative work 
with children and young people not using drugs but 
considered at risk is an important component of the work 
of the centre. 
Uniquely positioned at the heart of the community, the 
centre has offered a safe place for many children, young 
people and families to work through the challenges in their 
lives. Part of the charm and strength of the centre is that it is 
small – it has six staff and is based in what could be a family 
home, where the atmosphere and ambience is homely. One 
parent spoke movingly about how counselling sessions at the 
centre had changed his attitude to a drug user in the family 
and helped him to cope much better with the situation. 
Dr Siobhan Rooney, consultant psychiatrist, spoke of the 
centre’s reassuring approach:
When you walk through the door of the Talbot Centre, 
you are met with a warm, calm and welcoming 
atmosphere. The staff are professional, empathetic and 
hugely committed to their work. There is a healthy 
scepticism and intelligent filtering of what work needs to 
be prioritised by the staff in the service and the young 
person and their families always come first. My lasting 
impression is a sense of reassurance of what is being 
provided there and I know this is what young people and 
their families must feel when they leave to go back into 
the chaos they have to face. 
Project leaders Mary Cotter and Liam Roe confirmed the 
Talbot Centre’s approach to its work: ‘If it is too narrow to 
work with the child or young person in isolation from the 
family, it is too narrow to work with the family in isolation 
from the community.’ 
(Mary Cotter and Liam Roe)
1. Talbot Centre project team (2014) Thirty years  
of the Talbot Centre. Dublin: The Talbot Centre.  
www.drugsandalcohol.ie/21605
Mary Cotter and Liam Roe, Project Leaders The Talbot Centre, 
Addiction Service, HSE, DNE
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Recent publications
Journal articles
The following abstracts are cited from recently published 
journal articles relating to the drugs situation in Ireland.
Drinking motives and links to alcohol use in 13  
European countries 
Kuntsche E, Nic Gabhainn S, Roberts S et al.  
Journal of Studies on Alcohol and Drugs, 2014, 75(3):  
428–437.  
www.drugsandalcohol.ie/21828
The purpose of this study was to test the structure and 
endorsement of drinking motives and their links to alcohol 
use among 11–19-year-olds from 13 European countries, 
including Ireland.
The findings confirmed the hypothesized four-dimensional 
factor structure. Social motives for drinking were most 
frequently indicated, followed by enhancement, coping, 
and conformity motives, in that order, in all age groups in 
all countries except Finland. This rank order was clearest 
among older adolescents and those from northern European 
countries. The results confirmed that, across countries, 
social motives were strongly positively related to drinking 
frequency, enhancement motives were strongly positively 
related to frequency of drunkenness, and conformity motives 
were negatively related to both alcohol outcomes. Against 
our expectations, social motives were more closely related 
to drunkenness than were coping motives, particularly 
among younger adolescents. The findings reveal striking 
cross-cultural consistency. Health promotion efforts that are 
based on, or incorporate, drinking motives are likely to be 
applicable across Europe. As social motives were particularly 
closely linked to drunkenness among young adolescents, 
measures to impede the modeling of alcohol use and skills 
to resist peer pressure are particularly important in this 
age group.
Emotional labour in harm-reduction practice in Ireland: 
an exploratory study 
Fabianowska J and Hanlon N 
Irish Journal of Applied Social Studies, 2014, 13(1): 53–65. 
www.drugsandalcohol.ie/21634
Arlie Russell Hochschild’s concept of emotional labour has 
been applied extensively in the analysis of the emotional, 
relational and identity processes in a wide variety of 
service occupations, and to a lesser extent to caring 
occupations where the central goal is nurturing. It has 
featured infrequently in social care in general and has not 
featured significantly in academic debates in Ireland. The 
paper is based on a small qualitative study of social care 
workers in harm reduction [HR] day services in the Dublin 
region. The aim of the research study was to explore how 
emotional labour impacts on workers employed in day harm 
reduction services. The paper highlights the centrality of 
emotional labour in negotiating and managing a sense of 
professionalism and personal space within a highly stressful 
area of social care. The workers’ emotional labour involved a 
process of embodying professionalism, an empathic alertness 
in their relations with service users, emotional distancing 
from traumatic experiences, and developing caring spaces in 
personal and professional life. By considering the emotional 
labour of care workers, we can better understand the 
construction of identity within particular contexts. The 
research raises questions about the status of Harm Reduction 
and other emotional workers, the sufficiency of the 
knowledge base for practitioners, and important issues about 
how to develop and organise caring workplaces. 
The ebb and flow of attitudes and policies on alcohol in 
Ireland 2002–2010 
Hope A  
Drug and Alcohol Review, 2014, 33(3): 235–241. 
www.drugsandalcohol.ie/21601
This paper examines the level of public support for alcohol 
control policies during a period of policy evolution in 
Ireland. A comparison of attitudes to alcohol policy at three 
points in time was undertaken. The first survey took place in 
2002 and was repeated in 2006 and 2010 using a national 
quota sample of 1000 adults with face-to-face interviews. 
Policy areas examined were drunk-driving, price, availability 
and promotion.
In 2002, the highest level of public support was for drink-
driving countermeasures (84% favoured random breath 
testing) and measures to restrict alcohol promotions (67% 
favoured restrictions). Support for stricter measures on 
price and availability was lower. Trends showed a decline in 
support for tax increases and for early closing time, whereas 
support for fewer outlets (off-trade) increased.
When public concerns (level of support) for stricter alcohol 
policies were seen to be meet, as occurred with price and 
hours through increased tax and reversal of opening hours, 
public concern/support declined. When concerns were 
not met, as with outlets, support continued to rise most 
likely influenced by greater number of off-trade outlets and 
cheaper alcohol. Support for liberal alcohol policies was 
low and the majority favoured the status quo on price and 
availability. Public support for policy is one element of the 
complexity of policymaking along with consensus building 
across government and management of vested interests, so 
that the policy outcome is seldom assured. 
Down in the wards: point prevalence of antidepressant 
and benzodiazepine use 
Keenan R and O’Hare J 
Irish Medical Journal, 2014, 107(5).  
www.drugsandalcohol.ie/21557
Letter: The point prevalence use of anti-depressant (AD) use 
in Ireland in 2011 was 5.5 % and benzodiazepine (BDZ) 
use was 4.1%. Depression is under-recognised and under-
treated in hospitalised patients but the prevalence of AD use 
in acute general medical inpatients has been little studied 
internationally and unknown in Ireland. We report the point 
prevalence of AD and BZD use in a general medical hospital 
inpatient population. 
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A prospective cohort study of alcohol exposure in early 
and late pregnancy within an urban population in Ireland.
Murphy D, Dunney C, Mullally A et al. 
International Journal of Environmental Research and Public 
Health, 2014,11(2): 2049–2063.  
www.drugsandalcohol.ie/21551
Most studies of alcohol consumption in pregnancy have 
looked at one time point only, often relying on recall. The 
aim of this longitudinal study was to determine whether 
alcohol consumption changes in early and late pregnancy 
and whether this affects perinatal outcomes. We performed 
a prospective cohort study, conducted from November 2010 
to December 2011 at a teaching hospital in the Republic of 
Ireland. Of the 907 women with a singleton pregnancy who 
booked for antenatal care and delivered at the hospital, 185 
(20%) abstained from alcohol in the first trimester but drank 
in the third trimester, 105 (12%) consumed alcohol in the first 
and third trimesters, and the remaining 617 (68%) consumed 
no alcohol in pregnancy. Factors associated with continuing 
to drink in pregnancy included older maternal age (30–39 
years), Irish nationality, private healthcare, smoking, and a 
history of illicit drug use. Compared to pre-pregnancy, alcohol 
consumption in pregnancy was markedly reduced, with the 
majority of drinkers consuming ≤ 5 units per week (92% in 
first trimester, 72–75% in third trimester). Perhaps because of 
this, perinatal outcomes were similar for non-drinkers, women 
who abstained from alcohol in the first trimester, and women 
who drank in the first and third trimester of pregnancy. Most 
women moderate their alcohol consumption in pregnancy, 
especially in the first trimester, and have perinatal outcomes 
similar to those who abstain.
Genetic pre-determinants of concurrent alcohol and 
opioid dependence: a critical review 
Martin M, Klimas J, Dunne C et al.  
Open Access Alcohol, 2013, 1(2): 18p.  
www.drugsandalcohol.ie/21527 
Concurrent alcohol dependence poses a significant burden 
to health and wellbeing of people with established opioid 
dependence. Although previous research indicates that both 
genetic and environmental risk factors contribute to the 
development of drug or alcohol dependence, the role of 
genetic determinants in development of concurrent alcohol 
and opioid dependence has not been scrutinised.
To search for genetic pre-determinants of concurrent alcohol 
and opioid dependence, electronic literature searches were 
completed using MEDLINE (PubMed) and EBSCO (Academic 
Search Complete) databases. Reference lists of included 
studies were also searched. In this discussion paper, we 
provide an overview of the genes (n=33) which are associated 
with the opioid, serotonergic, dopaminergic, GABA-ergic, 
cannabinoid, and metabolic systems for each dependency 
(i.e., alcohol or opioid) separately.
The current evidence base is inconclusive regarding an 
exclusively genetic pre-determinant of concurrent alcohol 
and opioid dependence. Further search strategies and original 
research are needed to determine the genetic basis for 
concurrent alcohol and opioid dependency.
Association of educational attainment and adolescent 
substance use disorder in a clinical sample 
Apantaku-Olajide T, James P and Smyth B P  
Journal of Child & Adolescent Substance Abuse, 2014, 23(3): 
169–176. 
www.drugsandalcohol.ie/21868
This study explores substance use, psychosocial problems, 
and the relationships to educational status in 193 adolescents 
(school dropouts, 63; alternative education, 46; mainstream 
students, 84) who attended a substance abuse treatment 
facility in Dublin, Ireland. The study found that the 3 
groups exhibited statistically significant differences in their 
substance use problems, with the school dropouts displaying 
significantly more problems. The need for early detection 
and intervention of at-risk students, and collaborative 
interagency work aimed at addressing substance use, cannot 
be overemphasized as strategies to ultimately prevent 
school dropout.
Development and process evaluation of an educational 
intervention to support primary care of problem alcohol 
among drug users 
Klimas J, Lally K, Murphy L et al.  
Drugs and Alcohol Today, 2014, 14(2). 
www.drugsandalcohol.ie/21886
This paper describes the development and process evaluation 
of an educational intervention, designed to help general 
practitioners (GPs) identify and manage problem alcohol use 
among problem drug users.
The educational session was developed as part of a complex 
intervention which was informed by the Medical Research 
Council framework for complex interventions. A Cochrane 
review and a modified Delphi-facilitated consensus process 
formed the theoretical phase of the development. The 
modelling phase involved qualitative interviews with 
professionals and patients. The training’s learning outcomes 
included alcohol screening and delivery of brief psychosocial 
interventions and this was facilitated by demonstration of 
clinical guidelines, presentation, video, group discussion and/
or role play.
Participants (N=17) from three general practices and local 
medical school participated in four workshops. They perceived 
the training as most helpful in improving their ability to 
perform alcohol screening. Most useful components of the 
session were the presentation, handout and group discussion 
with participants appreciating the opportunity to share their 
ideas with peers. Training primary healthcare professionals 
in alcohol screening and brief psychosocial interventions 
among problem drug users appears feasible. Along with the 
educational workshops, the implementation strategies should 
utilise multi-level interventions to support these activities 
among GPs.
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September
1 September 2014
Understanding and managing cyber bullying 
National Cyber Bullying Conference 
Venue: Main conference centre, Dublin Castle 
Organised by: Bully4u and National Anti-bullying  
Centre, DCU 
Email: jim@bully4u.ie 
Web: http://bully4u.ie/national-cyberbullying- 
conference-ireland/ 
Information: This conference will be of particular interest to 
parents, principals, deputy principals, guidance counsellors, 
boards of management, parents associations, academics, 
legal professionals and health care professionals. Attendance 
at this conference will support a school management’s 
education requirements under the government’s anti-
bullying guidelines. The conference will be opened by  
Mr Sean Kelly MEP and chaired by Ms Mary Mitchell 
O’Connor TD. Further information and tickets available  
at www.cyberbullyingconference.ie 
23 September 2014
Reporting for Work under the Influence of Drugs and 
Alcohol – Employers Legal Obligations
Venue: The Maldron Hotel, Cardiff Lane, Dublin 
Organised by: EAP Institute 
Email: anita@eapinstitute.com 
Web: www.eapinstitute.com/drugalcohol.asp 
Information: Seminar presented by Maurice Quinlan, 
Director, EAP Institute. Under the Safety, Health and Welfare 
at Work Act 2005 all employees must ensure that they are 
not under the influence of an intoxicant (defined as including 
drugs and alcohol and any combination of drugs or of drugs 
and alcohol) to the extent that he or she is in such a state as 
to endanger his or her own safety, health or welfare at work 
or that of any other person.
Safety critical companies and those with safety critical 
workers are obliged to conduct risk assessments and 
identify those who would be a danger to themselves 
and others if they report for work under the influence of 
intoxicants. Seminar presented by Maurice Quinlan, Director, 
EAP Institute.
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